Revised 03/04/2015

CURRICULUM VITAE - KATHLEEN B. SCHWARZ, M.D.

I. PERSONAL DATA

NAME: Kathleen Ann Brogan Schwarz, M.D.

II. EDUCATION AND PROFESSIONAL TRAINING

Years Institution Degree

1960-1964 Scripps College BA Biology

Claremont, CA

1964-1965 Northwestern University MAT Biology

Evanston, IL & French

1968-1970 Universidad Central de Venezuela

Facultad de Medicine, Caracas

Venezuela

1967-1972 Washington University MD

School of Medicine

St. Louis, MO

1972-1973 Intern in Pediatrics

St. Louis Children's Hospital

Washington University School of Medicine

1973-1974 Second Year Assistant Resident in Pediatrics St. Louis Children's Hospital

1974-1976 Fellow in Pediatric Gastroenterology and Nutrition St. Louis Children's Hospital

(half-time)

1976-1977 National Institute of Health Trainee in Medicine (Gastroenterology) Barnes

Hospital, Washington University School of Medicine, St. Louis, MO

-2-

III. PROFESSIONAL EXPERIENCE

1977-1978 Instructor in Pediatric Gastroenterology, Washington University,

Department of Pediatrics, St. Louis Children's Hospital

1977-1978 Instructor in Medicine, Washington University Department of Internal

Medicine Barnes Hospital

1978-1983 Assistant Professor of Pediatrics, Chairman, Division of Pediatric

Gastroenterology, St. Louis University School of Medicine

1983-1987 Associate Professor of Pediatrics, Chairman, Division of Pediatric

Gastroenterology, St. Louis University School of Medicine

1978-1987 Member, full-time staff, Cardinal Glennon Children's Hospital

1978-1987 Member, Medical Staff, St. Louis University Hospital

1987-1989 Assistant Professor of Pediatrics, Division of Pediatric Gastroenterology

and Nutrition, Johns Hopkins University School of Medicine

1987-1992 Member, full-time staff, University of Maryland Medical Systems

1989-Present Associate Professor of Pediatrics, Division of Pediatric Gastroenterology and

Nutrition, Johns Hopkins University School of Medicine

1995-1998 Acting Chief, Division of Pediatric Gastroenterology and Nutrition,

Johns Hopkins University School of Medicine

1998 - 2004 Chief, Division of Pediatric Gastroenterology and Nutrition, Johns

Hopkins University School of Medicine

2000 - Present Professor of Pediatrics

-3-

IV. LICENSURE AND CERTIFICATION

Licensure: Maryland, Missouri

Specialty Certification:

1973 National Board of Medical Examiners

1977 American Academy of Pediatrics #21135

2006 American Board Pediatric Transplant Hepatology Certifying Exam

Subspecialty Certification:

1991 Pediatric Gastroenterology and Nutrition

1997 Pediatric Gastroenterology and Nutrition

2004 Pediatric Gastroenterology and Nutrition

2006 Transplant Hepatology Boards

V. HONORS AND AWARDS

1963 The Virginia Judy Esterly Junior Scholar, Scripps College

1964 The Virginia Judy Esterly Senior Scholar, Scripps College

1975 Commencement Speaker, Scripps College

1976 Marquis Who's Who in American Women

1985 Pediatric Housestaff Faculty Recognition Award, St. Louis University

School of Medicine

1987 Society for Pediatric Research

1988-90 Johns Hopkins University Clinician Scientist Award

1991 Marquis Who's Who in the East

1993 The Best Doctors in America

1993 Member, American Board of Pediatrics, Subboard in Pediatric Gastroenterology

1994 National Institute of Health, Clinical Sciences Special Emphasis Panel Study Section

1995-96 Who's Who in North America

1996 National Institute of Health - Invited participant Viral Hepatitis Working

Group (NIDDK)

1996-99 Secretary/Treasurer and member, Executive Council, North American Society of

Pediatric Gastroenterology and Nutrition.

1997 Credentials Board for Pediatric Gastroenterology Training Program ACCME

1997-Present Children’s Liver Council of the American Liver Foundation

1998 The Alexander J. “Buck” Schaffer Award for Outstanding Clinical Teachers of

Pediatric House Officers

1998 - 2003 Secretary/Treasurer Childrens Digestive Health and Nutrition Foundation

1998 - 9 National Academy of Sciences, Institute of Medicine. Dietary Antioxidant Panel for

the Recommended Dietary Allowances.

1999 Top 25 Pediatricians in Baltimore

2000 -1 Guidelines for Children with Liver Disease - American Society of Enteral and

Parenteral Nutrition

2000 National Institutes of Health (NIAID) Reviewer for new initiative HCV

and Hemophilia

-4-

2001 - Present Johns Hopkins Pediatrics at Home Inc., Board of Trustees

2001 - Present Castle Connolly Top Doctors in America

2002 Co-Director - First Pediatric Hepatology Course for the AASLD (American

Association for the Study of Liver Diseases) Emory Conference Center,

Atlanta,GA

2002, 2004 NIDDK Special Emphasis Panel ZDKI-GRB8-JI (RO3 Grants Review)

2004-2005 Guide to America’s Top Physicians

2005 Visiting Professor, Scripps College Lois Langland Alumnae in Residence

2004-2005 Guide to America's Top Pediatricians

2005 NASPGHAN Distinguished Service Award “In Recognition and Appreciation

of Outstanding Contributions to Pediatric Gastroenterology”

2005 NIDDK Special Emphasis Panel ZDK1-GRB-CM1 Ancillary Studies - HCV

2005 FDA Antiviral Drug Products Advisory Committee

Special Emphasis Panel RFP NIH NIAID DMID 05-12 "Animal models

for the Prevention and Treatment of Hepatitis B and Hepatitis C"

2005 NIH ZAT1 SM (01) Clinical Trials of Silymarin for Liver Disease

2005 AASLD Nominating Committee

2006 Distinguished Alumna, Scripps College

2007 Invited Speaker – Viral Hepatitis – at the Festschrift for Eve Roberts, University of

Toronto

2007 NIDDK ZDK1GRB8J Study Section Review of T32 Training Grant in Pediatric

Gastroenterology

2007 NIH ZAT1 Complementary and Alternative Medicine Trials for 2007

Arnold Silverman Visiting Professorship, University of Colorado HCV

2007 Cambridge Who’s Who Among Executive and Professional Women “Honors Edition”

2008 Patient Safety Star Award - Johns Hopkins University School of Medicine

2008 International Who’s Who Historical Society

2008 Chairman ABP Gastroenterology Self Assessment Exam

2008 - present Johns Hopkins University Master Clinician

2008 NIDDK Hepatobiliary Pathophysiology Study section – Invited Participant

2008 NIH Digestive Sciences and Bioengineering Small Business Grant – Grant Review

Study Section Liver Transplantation and Viral Hepatitis

2008 NIH Digestive Sciences Small Business Grant Review

2008 NIH/NIDDK Drug-Induced Liver Failure Study Section

2008 - present Castle Connolly Top Doctors in America

2008 - 14 President-Elect, President, President Emeritus (2 years each) of the North American

Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)

2009 Recipient of the Johns Hopkins University Women’s Network Leadership Award

for the Medical School (East Baltimore Campus)

2010 Antiviral Drugs Advisory Committee (AVDAC) consultant

2010 -11 Marquis Who’s Who in America

2011 Best Doctors in America

2012 – 16 President, FISPGHAN (Federated International Societies of Pediatric

Gastroenterology, Hepatology, and Nutrition)

2012 Washington University School of Medicine, Distinguished Alumna Award

-5-

2013 NIDDK Special Emphasis Panel Limited Competition for the Continuation of the Drug

Induced Liver Injury Network Data Coordinating Center (DILIN DCC)

2013 Theodore Roosevelt High School, Distinguished Alumna Award

2013 Member of Board of Infectious Diseases in Children

2014 Castle Connolly Top Doctors in America

2014 AASLD Fellow

2014 Ad Hoc Reviewer VA Epidemiology Study Section

2015 Castle Connolly Top Doctors in America

VI. PROFESSIONAL AFFILIATIONS

MEMBERSHIP IN PROFESSIONAL ORGANIZATIONS:

1978-1997 American Academy of Pediatrics

1978-Present North American Society for Pediatric Gastroenterology

1979-1983 American Society for Enteral and Parenteral Nutrition

1979-1987 St. Louis Pediatric Society

1982-1994 American Institute of Nutrition

1982-1994 American Society of Clinical Nutrition

1985-Present American Association for the Study of Liver Diseases

1987-2006 Society for Pediatric Research

1988-2006 American Gastroenterology Association

VII. NATIONAL COMMITTEES

1989-1991 Chairman, By-Laws Committee and Council Member North American

Society of Pediatric Gastroenterology

1992 Member, Nominating Committee, AGA Section on Growth and

Nutrition

1995-1999 Member, Credentials Committee, ABP Subboard in Pediatric

Gastroenterology and Chairman 1998

1996 Member Schwachman Award Committee, North America

Society of Pediatric Gastroenterology and Nutrition

1996 - 1999 Secretary/Treasurer, North America Society of Pediatric Gastroenterology

and Nutrition

1997 Member, Training and Education Committee, American Association for

the Study of Liver Diseases

1997 Cystic Fibrosis Foundation Liver Disease Working Committee

-6-

2000 North American Society for Pediatric Gastroenterology and Nutrition -

Long Range Strategic Planning Committee

2001 - NASPGHN Hepatology Committee

2002 - Children's Liver Council/American Liver Foundation

2003 - 2004 NASPGHN Finance Committee

2003 - 2004 Chairman CDHNF Finance Committee

2003 - NASPGHN Nominating Committee

2004 - Scientific Advisory Board, Hepatitis Foundation International

2004 - Medical Second Opinions

2006 - AASLD Nominating Committee

2006 - NASPGHAN Awards Committee

2007 - Scientific Advisory Board

CDHNF

Campaign for Viral Hepatitis

AASLD Special Interest Group – Cholestatic Liver Disease

AASLD Special Interest Group – Pediatric Liver Disease

2008 - Chair Focused Study Group/Single Topic Conference

AASLD Pediatric SIG FSG/STC

2012-14 Chair, NASPGHAN Publications Committee

2013 FISPGHAN Expert Team on Viral Hepatitis

2013 Founding Member of the Board of Directors, Global Liver Institute

2012 – present NIDDK Hepatitis B Research Network: Chairman, Pediatric Committee,

Member Executive Committee, Ancillary Studies Committee, P and P

Committee

2006 – present NIDDK Children’s Liver Disease Research and Education Network: Chair,

Website and INH Committees, Member Biliary Atresia Clinical Trials

Committee

-7-

VIII. EDITORIAL APPOINTMENTS

Reviewer:

American Academy of Pediatrics Redbook 2013

American Journal Diseases of Children

American Journal of Gastroenterology

Archives Diseases of Children and Adolescents

Current Pediatric Reviews

Gastroenterology

Hepatology

Infectious Diseases in Children

Journal of Clinical Investigation

Journal of Pediatrics

Journal of Pediatric Gastroenterology and Nutrition

Laboratory Investigation

Medicine

Pediatric Infectious Disease

Pediatric Research

Journal of Pediatric Transplantation

American Journal of Respiratory and Critical Care Medicine

The Open Pediatric Medicine Journal

Hepatitis Scientific Advisory Board

Book Reviews: Schwarz KB, Biochemistry of the Essential Ultratrace Elements. Biochemistry

of the Elements, Volume 3 edited by Earl Frieden, Plenum Press, New York,

1984. Published in Quarterly Review of Biology, 1986.

Schwarz KB, Viral Hepatitis and Liver Disease, edited by Zuckerman. J Pediatr

Gastro and Nutr. (In press 1990).

Schwarz KB, Pediatric Gastroenterology and Nutrition. Edited by J.

Vanderhoof and W. Balistreri. Gastro (In Press 1991).

Karnsakul W, Schwarz KB. Hepatitis in Remington & Klein: Infectious

Disease of the Fetus and Newborn Child, 7th edition. Elsevier, (In Press)

2009.

Editorial board: Journal of Pediatric Gastroenterology and Nutrition (retired 2004)

Clinical Gastroenterology and Hepatology

Current Pediatric Reviews

Pediatric Infectious Disease Journal

-8-

IX. SELECTED INVITED LECTURES AND SYMPOSIA

1979 "Gastrointestinal Disorders in Children" Washington University School of

Medicine, Topic: "Fluid and Electrolyte Balance in Children with Ostomies"

1982 "Gastrointestinal Disorders in Children" Washington University School of

Medicine Keystone, CO

1982 "Emergency Care for Kids--Reye's Syndrome" Clinton County E.M.T.

Association, Breese, IL

1985 "Prolonged Elevation of Amino Transferases in Children with Unsuspected

Myopathy" Physician's Radio Network

1986 "Reye's Syndrome" Clinical Conference Speaker, St. Elizabeth's Hospital

Belleville, IL

1989 Moderator, Poster Symposia North American Society Pediatric

Gastroenterology and Nutrition, Chicago IL

1990 "Pediatric Liver Transplantation" Mercy Hospital, (Pediatric Ground Rounds),

Baltimore, MD

1990 "Viral Receptors", "Viral Hepatitis" Faculty member, Ross Symposium on

Pediatric Gastroenterology and Nutrition, Phoenix, AZ

1990 "Pediatric Liver Transplantation" (Hershey Medical Center, Pediatric Ground

Rounds), Hershey, PA

1991 "Update on Viral Hepatitis" Faculty member, University of Chicago Conference

on Pediatric Liver Disease, Chicago, IL

1991 "Hepatitis C" Topics in Gastroenterology (CME Course, JHMI)

1992 "Hepatitis B Vaccine" Peninsula General Hospital Pediatric Grand Rounds

1993 "Hepatitis B Virus: Bad News/Good News" Pediatric Grand Rounds, Johns

Hopkins Department of Pediatrics

1993 "Biliary Atresia: Ducts, Docs, and DNA" Grand Rounds, Division of Pediatric

Surgery, Johns Hopkins Hospital

1993 "Vitamin E" Minisymposium. FASEB, New Orleans, LA

1993 "Role of Viruses in Pediatric GI" Moderator, Trends, Baltimore, MD

-9-

1993 "Medical Management of Liver Failure" Johns Hopkins Update for Nurses,

Baltimore MD

1993 "Cystic Fibrosis Liver Disease" Symposium. CF Foundation, Dallas Texas

1994 "Consequences of Oxidative Stress: Clues to HBV Oncogenesis" Neurovirology

Seminar. Johns Hopkins University School of Medicine, Baltimore, MD

1994 "Hepatitis C" Pediatric Grand Rounds, St. Agnes Hospital, Baltimore, MD

1994 "Hepatitis C" Hemophilia Family Day, St. Agnes Hospital, Baltimore, MD

1994 "Vitamins" Moderator. Advances in Pediatric Nutrition (CME course) JHMI

1994 "Pediatric Gastroenterology Topics" Pediatrics for the Practitioner. JHMI

1995 α-Interferon Therapy of Hepatitis C in Hemophiliac Children. National

Hemophiliac Foundation, Atlanta, Ga.

1995 "Acute Liver Failure" Annual Ross Lecture. Pediatric Grand Rounds

University of Arkansas Department of Pediatrics

1995 "Update on Viral Hepatitis" Pediatric Grand Rounds. Fairfax Community

Hospital. Fairfax, Va.

1995 "Wilson's Disease, Johns Hopkins Hepatobiliary Course. Ocean City, MD.

1995 Antioxidant Effect of Vitamin A Supplementation in Premature Infants.

The Oxygen Society, Pasadena, CA

1996 ”Viral Hepatitis” Pediatric Grand Rounds. East Baltimore Medical

Center

1996 "Interferon for Hepatitis C" Annual Region III Hemophilia Treatment

Center Meeting. Bethesda, MD

1996 Hepatitis C Update. Saturday Pediatric Rounds. JHH

1996 Co-director - CME Course - JHU Hepatobiliary Update. Ocean City, MD

1996 “Gastro-esophageal Reflux” in Pediatrics for the Practitioner. Baltimore,

MD

1996 “Hepatitis C” Voice of America Radio Broadcast

-10-

1996 “Hepatitis C in Children” NIADDK - Viral Hepatitis Working Group

1996 “Hepatitis C: The Tip of The Iceberg” Pediatric Grand/Rounds. Johns

Hopkins

1997 “Oxidative Stress and HBV Hepatocarcinogenesis” - Adult

Gastroenterology Research Conference - Johns Hopkins University

1997 “Viral Hepatitis in Children” - Pediatric Grand Rounds

Franklin Square Hospital, Baltimore, Maryland

1997 “Vital Signs” ABC TV program on a Johns Hopkins pediatric liver

transplant patient

1997 “Interferon for Hepatitis C” - Region III Hemophilia Treatment Center

Annual Meeting - Wilmington, Delaware

1997 “Role of Oxidative DNA Damage in Hepatitis B Hepatocarcinogenesis” -

Adult GI Research Conference Johns Hopkins Medical Institutions

1997 “Update in Viral Hepatitis” - Franklin Square Hospital Pediatric Grand

Rounds

1997 “Update in Viral Hepatitis” - Johns Hopkins Transfusion Medicine Group

1997 “Hepatitis C in Hemophiliac Children” - National Hemophiliac Foundation

Region II Delaware

1997 “Management of Hepatitis C” - Topics in Gastroenterology, CME Course

Johns Hopkins Medical Institution

1997 “Hepatitis C in Hemophiliac Children” - National Hemophiliac Foundation

Region III New Jersey

1997 “Autoimmune hepatitis” NASPGN Annual meeting Toronto, Canada

1997 “Pediatric Liver Transplantation” - Pediatric Grand Rounds, Sacred Heart

Hospital, Cumberland, MD

1998 Update in Pediatric Hepatitis C Region II Hemophilia Treatment Center Annual

Meeting. Alexandria, VA.

1998 “Viral hepatitis” VCR and NBC television program for the American Liver

Foundation

-11-

1998 Role of Oxidative DNA Damage in Viral Hepatocarcinogenesis - USDA

Research Seminar

1998 “Neonatal Cholestasis” CD Rom for the Johns Hopkins Comprehensive

Transplant Center

1998 Pediatric G.I. Techniques in the Era of Cost Containment

Johns Hopkins Trends

1998 Liver/Small Bowel

Johns Hopkins Trends

1998 Challenges in Pediatric Transplantation

Johns Hopkins Trends

1998 Johns Hopkins Hepatobiliary Update

Ocean City, Maryland

1998 Transplant Lifestyles

Ocean City, Maryland

1999 Moderator - Treatment of Hepatitis B & C

AASLD Symposium AGA Annual Meeting - Orlando, Fl

1999 Immunopathogenesis of Hepatitis C in Children

Adult Gastroenterology Research Conference - Johns Hopkins

1999 Moderator - Symposium on Viral Infection in Hepatobiliary Disease

NASPGN Annual Meeting - Denver, Colorado

1999 Hepatitis C in Hemophiliac Children - National Hemophilia Foundation Annual

Meeting - Dallas, Texas

1999 Co-Director Symposium on Viral Infection of the Liver in Children

AASLD Annual Meeting - Dallas, Texas

1999 Meet-the-Professor Luncheon - Pediatric Viral Hepatitis

AASLD Annual Meeting - Dallas, Texas

2000 Chronic Liver Disease during Adolescents. Annual Meeting of the Society of

Adolescent Medicine - Arlington, VA.

2000 NIH Consensus Conference - Viral Hepatitis a-interferon Therapy of

Children with Hepatitis B

2000 Hepatitis C in Children - Mercy Medical Center - Baltimore, MD.

-12-

2000 Hepatitis C in Children -Meet-the-Professor - First World Congress of Pediatric

Gastroenterology, Hepatology and Nutrition, Boston, MA

2000 Moderator: Focused Study Group Alagille Syndrome: The Jagged Edge

AASLD Annual Meeting

2001 Ross Conference for Pediatric GI Fellows - What? When? Why? DRI's

Camelback, Arizona

2001 Anesthesia Grand Rounds: Neuropsychological Outcome of Children Post

Liver Transplantation

2001 GI Topics Course - Hepatitis B - Should it be treated?

2002 Pediatric Viral Hepatitis - HepDART Conference Northwestern University

CME Course, Maui, Hawaii

2001 Treatment of Viral Hepatitis in Children - Pediatric Grand Rounds, St. Agnes

Hospital, Baltimore, Maryland

2001 Pediatric Liver Transplantation - Sacred Heart Hospital, Cumberland, Maryland

2003 Johns Hopkins Comprehensive Transplant Center Video

2001 Invited Participant FDA Pediatric Advisory Subcommittee: Pediatric HCV Trials

2002 Co-Moderator: “Treatment of Viral Hepatitis in Children” 52nd

Annual Meeting –

AASLD - Dallas, Texas

2002 Pediatric Hepatitis C. Franklin Square Hospital Pediatric Grand Rounds,

Baltimore, Maryland

2004 Pediatric Liver Transplantation Video - Fujisawa Corporation

2002 Moderator Pediatric Gastroenterology Session - Annual Meeting of the Society

for Pediatric Research, Baltimore, Maryland

2002 Moderator - Food Allergy Planary Session- Annual Meeting North American

Society of Pediatric Gastroenterology, Hepatology and Nutrition, San Antonio,

Texas

2004 Invited Speaker: Chronic Hepatitis in Children - "Hepatitis C Virus" for the

AGA - Digestive Disease Week - May 18, 2004 New Orleans, Louisiana

2004 Meet the Professor - Treatment of HBV HCV and Career Development and

-13-

Mentoring - and Do We Need to Treat Hepatitis C? World Congress of

Pediatric Gastroenterology, Hepatology and Nutrition

2004 Meet the Professor - Viral Hepatitis and Pediatric Populations AASLD Annual

Meeting, Boston, Mass

2004 Early Morning Workshop - Treatment of Hepatitis C in Children - AASLD

Annual Meeting, Boston, Mass

2005 Lois Langland Alumna in Residence, Scripps College, Claremont, CA

2005 “31st Annual Topics in Gastroenterology and Liver Disease” Hepatitis Session

September 2005

2006 Invited Professor – Ross Conference for Advanced Fellows in Pediatric

Gastroenterology, Carefree, Arizona, 2006

2007 Invited Professor AASLD Annual Meeting Focused Study Group/Pegylated

Interferon + Ribavirin for Hepatitis C

2007 Pediatric HCV Roche Medical Affairs Research Summit, Chicago Ill.

2008 Invited Faculty Mt. Sinai School of Medicine Pediatric Liver Symposium -

“Viral Hepatitis in Children”

2008 Invited Faculty Pediatric Hepatitis B: Hepatitis B Foundation

2008 34th

Annual Topics in Hepatobiliary Disease: Inherited Liver Disease in Children

and Adults , Johns Hopkins

2008 Controversies in the Treatment of Viral Hepatitis NASPGHAN

Annual Meeting, San Diego, California

2008 Invited Presenter: “Impact of HBV in Women and Children”

House of Representatives Subcommittee Hearing, The Capital, Washington DC

2008 Invited Presenter: Maryland Viral Hepatitis Task Froce

2008 Moderator: Focused Study Group on Alagille’s Syndrome: The Cutting Edge

AASLD Annual Meeting. San Francisco, California

2011 Learning Luncheon HCV in children – NASPGHAN Annual Meeting, Orlando,

Fla Update on the Management of HBV and HCV in Children – Latin American

Society of Pediatric Gastroenterology – Santo Domingo, Dominican Republic

-14-

2012 Senior Faculty Ross Conference for Pediatric Gastroenterology Fellows,

Phoenix, Arizona – Negotiating a Contract

How Do We Treat Hepatitis C in Pediatrics? American Gastroenterology

Association Annual Meeting – San Diego, California

Cholestasis – Mexican Pediatric Society Annual Meeting, Mexico City, Mexico

Hepatitis B in Children – Pediatric Academic Societies – Boston, Mass

There’s a Liver Mass on Ultrasound – NASPGHAN Annual Postgraduate Course,

Salt Lake City, Utah

2013 Pediatric Liver Disease Awareness presentation at the Senate Office Building,

Washington, DC

Neonatal Cholestasis: An Emergency of a Different Kind. Pediatric Grand

Rounds, York Hospital, York, Pa

Metabolic Liver Disease in the Neonate; Metabolic Liver Disease in the Child;

Hepatic Malignancies - Kunwar Viren Oswal Course in Pediatric

Gastroenterology, Hepatology, Liver Transplantation and Nutrition – New Dehli,

India

2014 Pediatric Metabolic Liver Disorders; Diagnostic Challenges via Case CHOICE

Atlanta, GA

X. RESEARCH SUPPORT

1978 Washington University Clinical Research Center, Grant #44-00036, "Sodium

and Water Balance in the Infant with Ileostomy." P.I. (50% effort)

1979-1987 John F.J. Mackiewicz Memorial Fund-Cardinal Glennon Children's Hospital,

"Phosphorus Metabolism in Reye's Syndrome." P.I. ($30,000)

1980-1982 Mead Johnson Nutritional Division, "Acceptance, Tolerance and Growth of

Compromised and Potentially Compromised Infants for Whom Nutramigen is

Prescribed." P.I. ($10,000)

1981-1987 Peter Duvall Nutrition Research Fund, P.I. ($10,000)

1984-1987 National Institute of Health, R23 NS20835.02 "Lipid Peroxidation and

Antioxidants in Reye's Syndrome." P.I. ($107,500)

1988-1990 Johns Hopkins University Clinician Scientist Award, "Viral Hepatitis and

Iron-Induced Lipid Peroxidation." ($80,000)

-15-

1989-1990 National Reye's Syndrome Foundation, "Aspirin and Influenza B in Human

Hepatocytes." P.I. ($30,000)

1989-1990 Biological Science Research Grant, "Viral Hepatitis and Iron-Induced Lipid

Peroxidation." P.I.($7,500)

1991-1994 National Institute of Health R01HD28070-01 "Breath Ethane: Biomarker of

Vitamin A and E Deficiency" P.I. ($222,959)

1991-1992 Stetler Research Fund for Women Physicians "Role of Woodchuck Hepatitis

Virus in Promoting Oxidative DNA Damage in Primary Woodchuck

Hepatocytes" Sponsor for Dr. Molly O'Gorman. ($30,000)

1991-1992 Thomas Wilson Sanitarium Award "Breath Ethane: Biomarker of Vitamin A

and E Deficiency" P.I. ($10,000)

1993-1996 National Institute of Health Small Cancer R03CA59808-01A1 "Oxidative DNA

Damage and Hepatitis B Virus Oncogenesis" P.I. ($50,000)

1993-1995 Cystic Fibrosis Foundation Award "Breath Pentane and a Non-Invasive

Measure of Liver Function in Patients with Cystic Fibrosis" Sponsor for Dr.

Jeffrey Rosensweig. ($60,000)

1993 Biological Science Research Grant "Utility of Bile to Study Hepato Protective

Effects of Nutrient Antioxidants" (Technician salary) ($7,500)

1994 Cystic Fibrosis Foundation Student Research Award

"Transforming Growth Factor Beta as a Biomarker of Cystic Fibrosis Associated

Liver Disease", (Sponsor for Kathleen Page)($1,500)

1996 Cystic Fibrosis Foundation Clinical Research Grant Transforming Growth

Factor Beta in CF Liver Disease. $30,000

1997 The Thomas Wilson Sanitarium Foundation Grant

Hepatitis C in Baltimore City Children. $15,000.

1997-2000 National Institute of Health (Pediatric Hepatitis C)

Supplement to U19A140035 At the Southeastern Cooperative

Hepatitis C Research Group@. Co-Investigator $311,282

1997 National Hemophilia Foundation and Schering-Plough Corp. A Multi-center trial

of Intron A + Ribavirin for Treatment of Patients with Inherited Coagulation

Disorders and Chronic Hepatitis C@ - Co-investigator 1998 - 2000 -

$1000/patient

-16-

1999-02 “A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety

and Efficacy of 52 Weeks Lamivudine Treatment of a Dose of 3mg/kg in

Pediatric Subjects with chronic Hepatitis B”. Co-Investigator $157,615.

1999-01 Neuropsychological Outcome Following Pediatric Liver Transplantation

P.I. Kathleen B. Schwarz, M.D. $50,000

2000-03 Pegylated Interferon in Children with Chronic HCV: A Multi-Center

Trial. P.I. Kathleen B. Schwarz, M.D. Hoffman La Roche

06/01/00 - 06/01/03 $45,207

2000-03 IL-12 and IFN gamma Production in Children Receiving Pegylated Interferon

(PEG) Therapy for Chronic Hepatitis C (HCV)

06/01/00 - 06/01/03 Co-Investigator - Roche $180,000

2000 Immunodiagnostic use of a divalent peptide MHC-Ig Complex in patients

with rejection following orthotopic liver transplant (OLT) or with chronic

hepatitis C Virus (HCV) infection , Johns Hopkins Comprehensive Transplant

Center Pilot Project. P.I. Kathleen Schwarz, M.D.$20,000

2000-05 Subproject: Pediatric Acute Liver Failure - Lee W, PI. RO1 DK58369-01

9/01/00 - 8/31/05 $400/per patient

2000-04 NIH RO1 Viral Hepatitis in Children of Injection Drug Users RO1 DA13743-02

Schwarz KB. 10/01/00 - 9/30/04 $1,000,000

2002-05 An Extended Stratified Follow-Up Study in Pediatric Subjects with Chronic Hepatitis

B who have completed Previous Lamivudine Studies. GlaxoSmith Kline Schwarz

KB. 6/27/02-2/28/03 $55,678

2003-2009 Pegylated Interferon +/- Ribavirin for Children with Chronic HCV (Multi-

center Trial) – NIDDK – UO1DK067767 - $3.4M - 9/30/03 – 8/31/09

KB Schwarz PI (supplemental funding of $3.4M by Hoffman LaRoche ).

2002-2009 Novel Antigen and T&B Cell Response in Biliary Atresia. UO1DK62503 9/24/02-

5/31/09. $264,795/yr Cholestatic Liver Disease Consortium and Cystic Fibrosis

Liver Disease. $50k/y

2005 - 2010 Adefovir Dipivoxil for the Treatment of Children with Chronic Hepatitis B.

Sponsor Gilead. 3/05-2/10. $124,909 direct costs K. Schwarz, PI (for Hopkins)

2005 – 2010 A Multi-Center Group to Study Acute Liver Failure in Children. Squires R, PI,

Schwarz KB Co-Investigator NIDDK UO199-08-30-03, $12,500 9/1/05-8/31/10

2008 - 2015 Effect of HBV DNA Methylation and the Mutant 1762 T/ 1764A on Viral Load

& HCC Hepatitis B Clinical Research Network UO1 DK 082916-01 $1,872.615

-17-

Direct Costs K Schwarz PI for Hopkins.

2007 - 2011 Evaluation of PK Study, Safety, Tolerability and Efficacy of Entecavir (ETV) in

Pediatric Patients with Chronic Hepatitis B Infection who are HBeAG-Positive.

Bristol Meyer Squibb AI463-028-008. Schwarz, KB, PI . $73,366.00

2008 – 2009 Studies in Pediatric Liver Transplantation (SPLIT) Emmes 5 UO1 DK061693

Schwarz, KB, PI $1,125

2009 Johns Hopkins Urban Health Institute -Health Care Issues in Homeless Children

Schwarz, KB. PI $5,000

2009 – 2014 The Johns Hopkins Pediatric Liver Center ChiLDREN Grant - U01 DK062503-8

NIH/NIDDK Schwarz ,KB. PI $1,378,637

2010 – 2014 The Peds C LTFU Protocol No. NV17424 (Schwarz) Hoffman La Roche

Pegylated Interferon +/- Ribavirin for Children with Chronic HCV the NV17424

Schwarz,KB PI Direct $632,880 IDC $ 215,179

2007 – 2013 Pediatric Entecavir AI-463-028-008 (Schwarz)

BMS

Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir

(ETV)

To evaluate the pharmacokinetics, safety, tolerability and efficacy of Entecavir in

Pediatric subjects with Chronic Hepatitis B virus Infection who are HBeAg-Positive.

$73,366

2010 - 2015 AI-463-189-003 (Schwarz)

BMS

Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) Versus

Placebo in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are

HBeAg-Positive. $56,343

2012 – 2014 A Two-Part, Open –Label, Single-Arm Phase ½ Study of Safety, Pharmacokinetics,

and Efficacy of Telaprevir in Combination With Peginterferon and Ribavirin in

Pediatric Subjects Aged 3-17 Infected With Genotype 1 Hepatitis C Virus.

Vertex

Direct $33,287 IDC $11,317 Total: 44,604

2013 – 2014 Development and Implementation of a feeding protocol for neonates following bowel

resection to improve feeding tolerance and reduce liver injury. Darla Shores, MD,

Kathleen B. Schwarz, MD, Lynn Mattis, RN. Thomas Wilson Grant $18,000

2012 – 2015 A phase IIIb parallel croup, open label study of pegylated interferon ala-2a

monotherapy compared to intreated control in children with HBeAg positive chronic

hepatitis NB. Kathleen B. Schwarz, M.D.

-18-

Genenetech (Roche)

Direct $75,388 IDC: 25, 628 April 2012 – March 2015

2013 – 2015 Stefany Honigbaum, MD, Clinical Research Award from the American College of

Gastroenterology in the amount of $10,000 for your project entitled, "The role of

LOXL2 in fibrosing pediatric lung and liver disease.”

2014 – 2016 Emilia Shin, MD, NIH T32 Department of Pediatrics, “The Utility of Whole Genome

Sequencing to Identify Susceptibility Genes and Infectious Triggers of Autoimmune

Hepatitis”.

XI. MAJOR ACADEMIC SERVICE

St. Louis University School of Medicine 1978-1987:

1978-1987 Lecturer in clinical nutrition to freshman and junior medical students as

part of a grant given to Dr. Robert E. Olson by the National Fund for

Medical Education to develop an integrated program of basic and clinical

nutrition in the Medical curriculum.

1978-1981 Physician's Assistant Program - Lectures in Infant Nutrition and Pediatric

Gastroenterology

1979-1987 Nutrition Education Committee

1980-1981 Co-Chairman Gastrointestinal Diseases Module for Sophomore medical

students

1978-1987 Attending physician, Division of Pediatric Gastroenterology and Nutrition

Cardinal Glennon Children's Hospital 1978-1987:

1978-1984 Chairman, Nutritional Advisory Committee

1978-1987 Total Parenteral Nutrition Team

1978-1987 Reye's Syndrome Management Team

1978-1980 Child Abuse Management Team

1979-1987 Intensive Care Unit Committee

-19-

1980-1984 Chairman, Housestaff Evaluation Committee

Johns Hopkins University and Hospital (1987 - present):

1987-present Attending physician, Pediatric Gastroenterology and Nutrition - 3-4

months/year

1998-2007 Attending physician, General Pediatrics-1 month/year

1987-2007 Pediatric Nutritional Advisory Committee

1989-1992 Medical School Admissions Committee

1988-2000 Director, Pediatric Gastroenterology Fellowship Program - Division of

Pediatric Gastroenterology and Nutrition

1989-present Medical Director, Johns Hopkins Pediatric Liver Center

1991-1998 Pediatric Clinical Research Unit Advisory Committee

1991-1995 Johns Hopkins Hospital Patient Satisfaction Committee

1991-1995 Johns Hopkins Hospital Organ Donor Committee

1993-present Member, Liver and Gastrointestinal Disease Teaching Team Sophomore

Pathophysiology Course

1996-2004 Member Organ and Tissue Donor Council JHMI

1996-present Member Pediatric Surgery Advisory Board Johns Hopkins Hospital

1996-1997 Gastroenterology Search Committee JHMI

1997- 2001 Member, JHH Radiology Advisory Committee

1997 PCRU Director - Search Committee, Department of Pediatrics

Johns Hopkins Medical Institution

1999 - 2001 Co-Director for Research - Comprehensive Transplant Center

2000 - 2004 Member GOR Performance Improvement Committee

-20-

2001 - 2003 Clinical Data and Documentation Committee

2001 - 2002 Committee for the Women’s Leadership Council

2002 – Present Member, Johns Hopkins Pediatrics at Home Board of Trustees

2004 Department of Pediatrics Performance Improvement Committee

2004 - present 3 PPC Subcommittees

2008 Director: Medical Student Elective Health Care Issues

In Homeless Children

XII. PUBLICATIONS:

1. Oberholzer VG, Schwarz, KB, Smith CH, Dietzler D, and Hanna TL, Microscale

modifications of a cation-exchange column procedure for plasma ammonia. Clin Chem

1976;22(12)76-81.

2. Schwarz, KB, Keating JP, Ternberg JL, and Bell MJ, Sodium balance following Soave

ileo-endorectal pull-through. J Pediatr Surg 1977;12:945-953.

3. Keating JP, Schwarz, KB, and Ternberg JL, An experience with total parenteral nutrition

in children. Am J Clin Nutr 1977;30:1506.

4. Schwarz, KB, Keating JP, Ternberg JL, and Holtmann B, Congenital lip pits and

submucous cleft palate; report of a case with Hirschsprung's disease involving the entire

colon and terminal ilem. J Pediatr Surg 1979;14:162.

5. Schwarz, KB, Goldstein P, Witztum JL, and Schonfeld G, Fat-soluble vitamin

concentrations in hypercholesterolemic children treated with colestipol. Pediatrics

1980;65:243.

6. Schwarz, KB, Witztum J, Schonfeld G, Grundy SM, and Connor WE, Elevated

cholesterol and bile acid synthesis in a young patient with homozygous familial

hypercholesterolemia. J Clin Invest 1979;64:756-760.

7. Schwarz, KB, Karl IE, and Alpers DH, Effect of intralumenal cation exchange resin on

excretion of ammonia in rat ileum. Pediatr Res 1981;15:1473-1477.

8. Schwarz, KB, Peden VH, and Craddock T, Zinc deficiency in a premature infant with

severe short bowel syndrome. Nutr Reviews 1982;40:81.

-21-

9. Schwarz, KB, Wolverson J, DeMello DE, King J, Nolan B, and Lewis JE, Budd-Chiari

Syndrome in a child. J Pediatr Gastr and Nutr 1982;1:277.

10. Schwarz, KB, Ternberg JL, Bell MJ, and Keating JP, Sodium needs of infants and

children with ileostomy. J Pediatr 1983;102:509-513.

11. Gurevitz M, DeMello DE, Tombaugh GC and Schwarz, KB, Reye's Syndrome (RS)

simulation in rats with elemental phosphorus. J Natl Reye's Syndrome Foundation

1982;3:32.

12. Kotagal S, Rolfe U, Schwarz, KB and Escober W, "Locked-In" State Following Reye's

Syndrome. Ann of Neurol, 1984;15 (6):599-601.

13. Schwarz, KB, Gurevitz M, Kanjanajjulpan P, Ylagan M, Schonfeld G and Fitch CD,

Decreased plasma vitamin E suggests role for lipid peroxidation in Reye's Syndrome

(RS). J Nat'l Reye's Syndrome Foundation 1983;4:59.

14. Schwarz, KB, Burris GC, DeMello DE, Hyams JS, Biller JA, Miksamak MG, Winter,

H.S., and Grand, R.J., Prolonged elevation of amino transferases in children with

unsuspected myopathy. Am J Dis Child 1984;138:1121-1124.

15. Schwarz, KB, Zimmerman DC, Alpers DH and Avioli LH, Gender differences in antacid-

induced phosphate depletion in rats. Gastroenterology 1985;89:313-320.

16. Knutsen A, Shah M, Schwarz, KB and Tsai CC, Graft versus host-like illness in a child

with phenobarbital hypersensitivity. Pediatrics 1986; Oct;78(4):581-4.

17. Gurevitz M, Weber T, Danis R, Craddock T, Grosfeld J, Ternberg JL and Schwarz, KB,

Sodium homeostasis in infants with biliary drainage procedures. Am J Dis Child

1986;140:535?538.

18. Schwarz, KB, Arey BJ and Mahanty, S. Aspirin stimulates malondialdehyde production.

J. of Nat'l Reye's Syndrome Foundation 1987;7:30-33.

19. Schwarz, KB, Larroya S, Kohlman L and Morrison A. Erythrocyte lipid abnormalities in

Reye's Syndrome. Pediatr Res 1987;21(4):352-356.

20. Schwarz, KB, Larroya S, Arey B, Vogler C and Schulze I. Influenza B Virus has

antioxidant effect in mouse liver mitochondria. J. Nat'l Reye's Syndrome Foundation

1987;7:47.

21. Schwarz, KB, Larroya S, Kohlman L, and Morrison A. Erythrocyte lipid abnormalities

in Reye's Syndrome. Pediatr Res 1987;21:352.

-22-

22. Arens MA, Knutsen AP, Schwarz, KB, Roodman SR and Swierkosz EM, Multiple and

persistent viral infections in a patient with bare lymphocyte syndrome. J Infect Dis.

1987;156:837.

23. Mings R, Knutsen AP, Krantman H, Schwarz, KB and Roodman SR, Chronic diarrhea in

a 5 month-old infant. Ann Allergy 1987;58:322, 372-374.

24. Gurevitz M, Schulze IT, Arens MQ, Swierkosz EM and Schwarz, KB, Effect of

influenza B virus on nutrient transport in cultured epithelial cells. Lab Invest

1987;57:657-664.

25. Schwarz, KB, Arey BJ, Tolman K and Mahanty S. Iron chelation as a possible

mechanism for aspirin induced malondialdehyde production by mouse liver microsomes

and mitochondria. J Clin Invest 1988;81:165.

26. Sotelo-Avila C, Danis RK, Krafcik J, Malik M and Schwarz, KB. Cholecystitis in a 17

year-old boy with recurrent jaundice since childhood. J Pediatr 1988;112:668.

27. Shah MD and Schwarz, KB, Hazards of small amounts of heparin in a patient with

subclinical vitamin K deficiency J Parent and Ent Nutr 1989;13:324-325.

28. Malik M, Connors R, Schwarz, KB, and O'Dorisio TM. Hormone-producing

ganglioneuroblastoma simulating intestinal pseudo obstruction. J Pediatr

1990;116(3):406-408.

29. Malik M, Schwarz, KB, Kotagal S. Syringomyelia and syringobulbia presenting as

pseudostricture of the cervical esophagus. J Pediatr Gastr Nutr 1990;11:115-117.

30. Schwarz, KB, Moore TJ, Willoughby RE and Yolken RE. Growth of Group A

rotaviruses in a human liver cell line. Hepatology 1990;12;4:638-643.

31. Schwarz, KB, Larroya S, Vogler C, Sippel CJ, Homan S, Cockrell R and Schulze I. Role

of Influenza B virus in hepatic steatosis and mitochondrial abnormalities in a mouse

model of Reye Syndrome. Hepatology 1991;12(1):96-103.

32. McCloskey J, Schleien C, Schwarz, KB, Klein A and Colombani P. Severe hypoxemia

and intrapulmonary shunting reversed by liver transplantation in a pediatric patient. J

Pediat 1991;118(6):902-904.

33. Refat M, Moore TJ, Kazui, M, Risby TH, Perman, JA and Schwarz, KB. Utility of

breath ethane as a noninvasive biomarker of vitamin E status in children. Pediatr Res

1991;30(5):396-403.

34. Risby TH, Maley W, Scott RP, Bulkley GB, Kazui M, Sehnert S, Schwarz, KB et al.

Evidence for free radical-mediated lipid peroxidation at reperfusion of human orthotopic

liver transplants. Surgery 1994;115:94-101.

-23-

35. Bancroft JD, Bucuvalas JC, Ryckman FC, Dudgeon DL, Saunders RC and Schwarz, KB.

Antenatal diagnosis of choledochal cyst. J Pediatr Gastr Nutr 1994;18:142-145.

36. Oliva MA, Todo S, Perman JA, Saavedra JM, Young J, and Schwarz, KB. Successful

intestinal transplantation for microvillus inclusion disease. Gastroenterology 1994;

106:771-774.

37. Schwarz, KB, Moore TJ, Sharma S, Clements MG, Seligman P. Activated THP-1 cells

depress mitochondrial respiration in Hep G2 cells infected with influenza B virus. Mol

Cell Probe 1994;8:345-351.

38. Ramos-Soriano AG, Schwarz KB. Recent advances in the hepatitides. Gastroenterol

Clin North Am. 1964 Dec;23(4):753-67.

39. O’Gorman MA, Fivush BA, Colombani P, Burdick J, Schwarz, KB. Proximal renal

tubular acidosis secondary to FK506 in pediatric liver transplant patients. Clin

Transplant 1995;9(4):312-316.

40. Ramos AG, Mitchell SE, Fair JE, Colombani PM, Schwarz, KB. Severe gastrointestinal

bleeding following liver transplant in young children. J Pediatr Gastr Nutr

1996;22(4):389-94.

42. Schwarz, KB, Cox J, Sharma S, Witter F, Clement L, Sehnert S, and Risby TH. Cigarette

smoking is pro-oxidant in pregnant women regardless of antioxidant nutrient intake. J

Nutr Med 1995;5:225-234.

43. Schwarz KB. Viral infection and oxidative stress. A review. Free Radical Bio Med

1996;21:641-649.

44. Bollinger ME, Arrendondo-Vega FX, Santisteban I, Schwarz, KB, Hershfield MS,

Lederman HM. Neonatal giant cell hepatitis as a complication of adenosine deaminase

(ADA) deficiency. N Engl J Med (May 23),1996;334:1367-1371.

45. Colombani PM, Cigarroa FG, Schwarz KB, Maley WE, Klein AS. Liver

transplantation in infants younger than 1 year of age. Ann Surg 1996;223(6):658-62.

46. Schwarz KB, Cox JM, Sharma S, Clement L, Witter F, Abbey H, Sehnert S, and Risby

TH. Pro-oxidant effects of maternal cigarette smoking in formula-fed newborns. J

Pediatr Gastr Nutr, 1997;24(1):68-74.

47. McKee M, Mattei P, Schwarz KB, Wise B, and Colombani P. Steroid withdrawal in

Tacrolimus (FK506)-treated pediatric liver transplant recipients. J Pediatr Surg,

1997;32(7):973-975.

-24-

48. Yokois N, Perlman E, Colombani PM, and Schwarz KB. Kaposi sarcoma presenting as a

protracted multisystem illness in an adolescent liver transplant recipient. Liver Transplant

Surg 1997;3(5):1-5.

49. Bobo L, Ojeh C, Chiu D, Machado A, Colombani PM and Schwarz KB. Lack of

evidence for rotavirus by polymerase chain reaction/enzyme immuno assay of

hepatobiliary samples in children with biliary atresia. Pediatr Res1997;41(2):

229-34.

50. Novy M, Schwarz KB. Nutritional considerations and management of the child with

liver disease. Nutrition 1997;13(3):177-184.

51. Schwarz KB, Cox JM, Sharma S, Clement L, Humphrey J, Gleason C, Helen Abbey,

Sehnert SS and Risby TH. Antioxidant effect of Vitamin A supplementation in

premature infants. J Pediatr Gastro & Nutr 1997;25:408-414.

52. Shneider BL, Fox VL, Schwarz KB, Watson CL, Ananthanarayanan M, Thevananther S,

Christie DM, Hardikar W, Setchell KDR, Mieli-Vergani G, Suchy FJ, Mowat AP.

Hepatic Basolateral Sodium-Dependent Bile Acid Transporter Expression in Two

Unusual Cases of Hypercholanemia and in Extrahepatic Biliary Atresia. Hepatology

1997;25(5):1176-1183.

53. Rosensweig JN, Masako O, Page K, Potter CJ, Perlman E, Thorgeirsson S. And Schwarz,

KB. Transforming Growth Factor Beta in Children with Biliary Atresia and Cystic

Fibrosis Associated Liver Disease. Pediatric Res 1998;44(3):402-409.

54. Schwarz KB, Cox J, Sharma S, Risby TH, Ogburn PL, VanWinter J, Kanayama M, Bibus D,

and Holman RT. Deficiency of n3 and n6 fatty acids in pregnancy: time course and effect of

antioxidant nutrients. J Nutr Envir Med 1999;8:335-344.

55. Orentas RJ, Lemas MV, Mullin MJ, Colombani PM, Schwarz KB, Ambinder R. Feasibility of

cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using

haploidentical donors. J Hematotherapy 1998 7:257-261.

56. Leung W, Colombani P, Lau H, Schwarz KB, Wise B, and Friedman A. Long term complete

remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorders

complicating liver transplant. Transplantation 1999;67(11):1487-9.

57. Choo-Kang LR, Benson J, Fry T, and Schwarz KB. Pneumatosis cystoides intestinalis

presenting with labial crepitus in an infant with acute lymphoblastic leukemia. J Ped Gastro

Nutr 1999;4:442-5.

58. Zellos A, Thomas D, Sharma S, Mocilnikar K, Stamato L, Perlman E, Boitnott J and Schwarz

KB. High viral load and mild liver injury in young hemophiliacs compared to other children

with hepatitis C virus (HCV) infection. J Pediatr Gastroenterol Nutr 1999;29:418-423.

-25-

59. Cohen M, Wise B, Stamato L, Colombani PM and Schwarz KB. Utility of liver biopsy culture

in pediatric liver transplant recipients. Pediatr Transplan. 1999 Nov;3(4): 322-7.

60. Praghakaran K, Wise B, Chen A, Schwarz K and Colombani P. Rational Management of

Posttransplant Lymphoproliferative Disorder in Pediatric Recipients. J Pediatric Surgery

Vol 34, No1 (January), 1999:pp112-116.

61. Colombani PM, Lau H, Prabhakaran K, Maley W, Wise B, Schwarz KB, and Klein A.

Cumulative experience with pediatric living related liver transplantation.

J Pediatr Surg 2000;35(01):9-12.

62. Schwarz KB, Zellos A. Efficacy of Octreotide in Children with Chronic Gastrointestinal

Bleeding. J Pediatric Gastroenterology and Nutrition. 30(4);April 2000;442-46.

63. Schwarz KB. Esophagocolonic fistula presenting as feculent emesis in a pediatric patient post

diaphragmatic hernia repair. Am Journal of Gastroenterology 08/2000 95(9):2561-2561.

64. Conner, KG, Schwarz KB. Guidelines for Children with Liver Disease - American

Society of Enteral and parenteral Nutrition JPEN Jan/Feb Supplement 2002 pg 202-

205.

65. Darbari A, Sabin KM, Shapiro CH, Schwarz KB. Epidemiology of Primary Hepatic

Malignancies in U.S. Children. HEPATOLOGY 2003 38(3);560-66.

66. O’Gorman MA, Sharma S, Groopman D, Tennart BC, Schwarz KB. Decreased oxidative DNA

damage and accelerated cell turnover in woodchuck hepatitis

Virus infected liver. Hepatology Research 2002;25(3);254-262.

67. Schwarz KB, Kew M, Klein A, Abrams R, Sitzmann J, Jones L, Sharma S, Britton R,

Di Bisceglie A and Groopman J. Increased hepatic oxidative DNA damage in patients with

hepatocellular carcinoma. Dig Dis Sci 2001 46(10):2173-2178.

68. Fan X, Solomon H, Schwarz KB, Kew MC, Ray RB and Di Bisceglie AM. Expression

of c-myc promoter binding protein (MBP-1), a novel eukaryotic repressor gene, in cirrhosis and

human hepatocellular carcinoma. Dig Dis Sci 46:(3)563 2001.

69. Jacobson K, Murray K, Zellos A and Schwarz KB. Meta-analysis of interferon monotherapy in

children with chronic hepatitis. J Pediatr Gastroenterol Nutr 2002;Jan;34(1):52-8.

70. Jonas MM. Kelley DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Little NR,

Greensmith MJ, Gardner SD, Bell MS, Sokal EM. Clinical trial of lamivudine in

Children with chronic hepatitis B. N Engl J. Med. 2002 May 30;346(22):1706-13.

71. Schwarz KB, Balisteri W. Viral Hepatitis. J Pediatr Gastroenterol Nutr. 2002;35 Suppl

1:S29-32.

-26-

72. Li, DY, Schwarz KB. Immunopathogenesis of chronic hepatitis C virus infection.

J Pediatr Gastroenterol Nutr. 2002;35(3):260-7.

73. Albayram F, Stone K, Nagey D, and Schwarz KB. Alagille Syndrome: Prenatal

Diagnosis and Pregnancy Outcome. Fetal Diagnosis and Therapy. Fetal Diagn Ther.

2002;17(3):182-4.

74. Oliva-Hemker M, Schwarz KB. Improving the status of clinical trials in pediatric

gastrointestinal diseases. J Pediatr Gastroenterol Nutr. 2002 Oct;35(4):468-9.

75. Alvarez F, Schwarz K. Immune diseases of the liver and biliary tract. J Pediatr

Gastroenterology Nutr. 2002:35 Suppl 1:S39-43.

76. Balistreri WF, Chang MH, Ciocca M. Schwarz K, Porta G. Acute and chronic hepatitis:

Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology

and Nutrition. J Pediatr Gastroenterol Nutr. 2002;35 Suppl 2:S62-73.

77. Schwarz KB, Rosensweig J, Sharma S, Jones L, Durant M, Potter C and Narkewicz MR.

Plasma markers of platelet activation in cystic fibrosis liver and lung disease.

J Pediatric Gastro Nutr. 2003 Aug;37(2):187-91.

78. DeRusso PA, Spevak MR, Schwarz KB. Fractures in Biliary Atresia Misinterpreted as Child

Abuse. Pediatrics 2003. Pediatrics 2003;112:185-8.

79. Li DY, Boitnott JB, Schwarz KB. Human herpes virus-6 (HHV-6): a cause for fulminant

hepatic failure or an “innocent bystander?”. J Pediatr Gastroenterol Nutr. 2003 Jul;37(1):95.

80. Schwarz KB. Pediatric Issues in new therapies for hepatitis B and C. Curr Gastroenterol Rep.

2003 June;5(3):233-9.

81. Li Ding You, Schwarz, KB. Enteritis necroticans with recurrent fistula caused by Clostridium

perfringens in a child with cyclic neutropenia. J Pediatr Gastroenterol Nutr. 2004-

Feb;38(2):213-5.

82. Li DY, Schwarz KB. Autoimmune hepatitis. Adolesc Med Clin. 2004 Feb;15(1):131-43, x.

83. Schwarz KB. Treatment of Pediatric HCV: at least two roads in the yellow woods.

Expert Viewpoint - Clinical Care Options for Hepatitis; www.clinicaloptions.com/hep.

In Press 2005

84. Molleston TP, Schwarz KB. Treating children with chronic hepatitis can be a challenge.

Infectious Diseases in Children; September 2004:68-69.

85. Oberto C, Schwarz KB , Zambidis E, Campbell AB, Paidas C, Lindyberg K, Oliva-Hemker, M.

Malignant mesothelioma mimicking inflammatory bowel disease. Dig Dis Sci 49:434-7;2004.

-27-

86. Schwarz KB, Garrett B, Barnes Y, Ashe SM, Turtle M, Lamoreus J, Bowser, YD, Bareta J,

Weinbaum C, Alter MJ. Hepatitis B Vaccination Rate of Homeless Children in Baltimore -

The Journal of Pediatric Gastroenterology and Nutrition. JPGN 41:225-229 - 2005

87. Klein WM, Molmenti EP, Colombani PM, Grover DS, Schwarz KB, Boitnott J and

Torbenson MS. Primary Liver Carcinoma in Children and Young Adults.

Am J Clin Pathol. 2005 Oct;124(4):512-8.

88. Shneider BL, Brown MB, Haber B, Sokol RJ, Whitington PF, Schwarz KB, Squires R, Bezerra

J, Shepherd R, Rosenthal P and Hoofnagle JH. A Multi-Center Study of Biliary Atresia

Outcome in the United States (1997-2000) Ms. No. 2005759R1 – The Journal of Pediatrics

148(4);467-474.e1(April 2006)

89. Byrnes AA, Li DY, Park K, Thompson D, Mocilnikar C, Mohan P, Molleston JP, Narkewicz

M, Zhou H, Wolf SF, Schwarz KB, Karp CL. Modulation of the IL-12/IFN-γ Axis by IFN-α

Therapy for Hepatitis C. J Leukocyte Biol. 2007 Mar;81(3);825-834. Epub 2006 Dec 15.

90. Sokal E, Kelly DA, Mizerski J, Badia IB, Areias JA, Schwarz KB, Vegnente A, Little NR,

Gardener SD and Jonas MM. Long Term Lamivudine Therapy for Children with HBeAg-

positive Chronic Hepatitis B. HEPATOLOGY 2006 Feb;43(2):225-32.

91. Squires RH, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A,

Rosenthal P, Rodriques-Baez N, Murray KF, Horslen S, Martin G, Lopez MJ, Soriano H,

McGuire BM, Jonas MM, Yazig N, Shepherd RW, Schwarz K, Lobritto S, Thomas DW, Lavine

JE, Karpen S, Ng, V, Kelly D, Simonds N, Lynan LS. Acute Liver Failure in Children: The

First 348 Patients in the Pediatric Acute Liver Failure Study Group – The Journal of Pediatrics

May 2006 652-658.e2

92. Hardikar W, Schwarz KB. Current Pediatric Reviews: Closing in on Biliary Atresia Current

Pediatric Reviews, ISSN: 1573-3963 - Vol 2, Number 4 , November 2006

93. Hardikar W, Schwarz KB. Treatment options for chronic hepatitis B and C infection in

children. Expert Rev Anti Infect Ther. 2006 Aug;4(4):583-91. Review

94. Schwarz KB, Mohan P, Narkewicz MR, Molleston JP, Nash SR, Hu S, Wang K, Gries JM.

Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40kd) in children with chronic

hepatitis C. J Pediatr Gastroenterol Nutr. 2006 Oct;43(4):499-505.

95. Schwarz KB, Garrett B, Hampsey J, Thompson D. High Prevalence of Overweight and

Obesity in Homeless Baltimore Children and their Caregivers: a Pilot Study. MedGenMed.

2007 Mar 7;9(1):48.

96. DeRusso PA Ye W, Shepherd R, Haber BA, Shneider BL, Whitington PF, Schwarz KB,

Bezerra JA, Rosenthal P, Karpen S, Squires RH, Magee JC, Robuck PR, Sokol RJ. A report

from the Biliary ATresia Research Consortium. A Longitudinal Study of Growth Failure and

Outcome with Biliary Atresia. Hepatology, 2007 Nov;46(5):1632-8.

-28-

97. Murray KF, Rodrique JR, Gonzales-Peralta RP, Shepherd J, Barton BA, Robuck PR, Schwarz

KB. Design of the PEDS-C Trial: Pegylated Interferon +/- Ribavirin for Children with Chronic

Hepatitis C Viral Infection. Clin Trials. 2007;4(6):661-73.

98. Jonas MM, Little NR, Gardner SD, Schwarz KB. Long-term lamivudine treatment of children

with chronic hepatitis B: durability of therapeutic responses and safety. J Viral Hepat 2007:

Online Early Publication. doi:10.1111/j.365-2893.007.00891.x. J Viral Hepat 2007;15(1):20-7.

99. Schwarz KB, Garrett B, Bowser Y, Alter MJ, Thompson D and Strathdee S. Seroprevalence of

Hepatitis C Virus in Homeless Baltimore Caregivers and their Children. Journal of Health

Care for the Poor and Underserved 19 (2008):580-587.

100. Schwarz KB, Zellos A, Stamato L, Thomas DL, Boitnot J, Perlman E, Chong S. Percutaneous

Liver Biopsy in Hemophiliac Children with Chronic Hepatitis C Virus Infection. J Pediatr

Gastroenterol Nutr. 2008 Apr;46(4):423-8.

101. Gonzales-Peralta R, Schwarz KB. Hepatocellular Carcinoma in Two Young Adoescents with

Chronic Hepatitis C. J Pediatr Gastroenterol Nutr. 2009 May;48(5):630-5.

102. Goodman ZD, Makhlouf HR, Liu L, Balistreri W, Gonzalez-Peralta RP, Haber B, Jonas MM,

Mohan P, Molleston JP, Murrary KD, Narkewicz MR, Rosenthal P, Smith LJ, Robuck PR,

Schwarz KB. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds C

Trial. Hepatology, 2008 Mar;47(3):836-43.

103. Schwarz KB, Garrett B, Lee J, Thompson D, Thiel T, Alter MJ, Strathdee S. Positive Impact of

a Shelter-based Hepatitis B Vaccine Program in Homeless Baltimore and Adolescents. Journal

of Urban Health: Bulletin of the New York Academy of Medicine, 2008. 85(2)doi:10.

1007/s11524-008-9253-3.

104. Rodrique JR, Balistreri W. Haber B, Jonas M, Mohan P, Molleston JP, Murray KF, Markewicz

MR, Rosenthal P, Smith LJ, Schwarz KB. Impact of Hepatitis C Virus (HCV) Infection in

Children: Quality of Life, Emotional, and Cognitive Outcomes. J Pediatr Gastroenterol Nutr.

2009 Mar;48(3):341-7. doi: 10.1097/MPG.0b013e318185998f

105. Kamath BM, Schwarz KB, Hadzic N. Alagille Syndrome and Liver Transplantation.

J Pediatric Gastroenterol Nutr 2010 Jan 50(1):11-5.

106. Fortunato JE, Schwarz KB. Outcome after Percutaneous Endoscopic Gastrostomy in Children

and Young Adults. J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):390-3. doi:

10.1097/MPG.0b013e3181aed6f1

107. Karnsakul W, Schwarz KB, Alford MK. “Managing pediatric hepatitis C: current and emerging

treatment options”. Ther Clin Risk Manag. 2009 Jun;5(3):651-60.

108. Haber B, Block J, Jonas M, Karpen S, London W, McMahon B, Murray K, Narkewicz M,

-29-

Rosenthal P, Schwarz KB. Recommendations for Screening, Monitoring and Referral of

Children with Chronic Hepatitis B in North America: Report of a Workshop. Pediatrics 2009

Nov;124(5):e1007-13. Epub 2009 Oct 5.

109. Foerster BR, Conklin LS, Petrou M, Barker PB, Schwarz KB. Minimal hepatic

encephalopathy in children: evaluation with proton MR spectroscopy. AJNR Am J

Neuroradiol. 2009 Sept:30(8):1610-3. Epub 2009 Jun 9.

110. Zellos A, Roy A, Schwarz KB. Use of oral naltrexone for severe pruritus due to cholestatic

liver disease in children. Journal of Pediatr Gastro Nutr 2010 Dec;51(6):787-9.

111. Zellos A, Schwarz KB. New-onset autoimmune hepatitis in young patients with preexisting

liver disease: A mere coincidence? Dig Liver Dis. 2010 Sept;42(9):657-60.

112. Jonas MM, Block JM, Haber BA, Karpen SJ, London WT, Murray KF, Narkewicz MR,

Rosenthal P, Schwarz KB, McMahon BJ; Hepatitis B Foundation. Treatment of Children

with chronic Hepatitis B virus infection in the United States: patient selection and therapeutic

options. Hepatology. 2010 Dec;52(6):2192-205.

113. Rabizadeh S, Schwarz KB. Bacterial Infections in Solid Organ Transplants Recipients.

e Transplant Infectious Diseases January 2010.

114. Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, Rosenthal

P, Mohan P, Balistreri WF, Narkewicz MR, Smith L, Lobritta SJ, Rossi S, Valsamakis A,

Goodman Z, Robuck PR, Barton BA, Peds-C Clinical Research Network. The combination of

ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents

with chronic hepatitis C. Gastroenterololgy 2011 Feb; 140(2);450-458 e1. Epub 2010 Oct 28.

115. Narkewicz MR, Rosenthal P, Schwarz KB, Drack A, Margolis t, Repka MX; PEDS-C Study

Group. J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):183-6.

116. Schwarz KB. Hepatitis C: not so indolent in survivors of pediatric cancer? Pediatr Blood

Cancer. 2010 Jul 15;55(1):7.

117. Alonso EM, Limbers CA, Neighbors K, Martz K, Bucuvalas JC, Webb T, Murray KF,

Narkewicz MR, Rosenthal P, Schwarz KB. Cross-sectional analysis of health-related quality of

life in pediatric liver transplant recipients. Studies of Pediatric Liver Transplantation (SPLIT)

Functional Outcomes Group (FOG). J Pediatr. 2010 Feb;156(2):270-6.

118. Limbers CA, Neighbors K, Martz K, Bucucalas JC, Schwarz KB, Webb T, Varni JW, Alonso

EM; Studies of Pediatric Liver Transplantation Functional Outcomes Group. Health-related

quality of life in pediatric liver transplant recipients compared with other chronic disease

groups. Pediatr Transplant. 2011 May;15(3):245-53.

-30-

119. Ling SC, McKiernan PJ, Walters T, Schwarz KB, Garcia-Tsai G, Shneider B. Primary

prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future

research. J Pediatr Gastroenterol Nutr. 2011 Mar;52(3):254-61.

120. Rodrigue JR, Haber B, Jonas MM, Molleston JP, Murray KF, Narkewicz MR, Roesnthal P,

Smith LJ, Schwarz KB, Robuck PR, Barton B, Gonzales-Peralta RP. Peginterferon with or

without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive

outcomes in children. Hepatology 2011 May;53(5):1468-75.

121. Omenetti A, Bass LM, Anders RA, Clemente MG, Francis H, Guy CD, McCall S, Choi SS,

Alpini G, Schwarz KB, Diehl AM, Whitington PF. Hedgehog Activity, Epithelial-

Mesenchymal Transitions, and Biliary Dysmorphogenesis in Biliary Atresia. Hepatology

2011 Apr;53(4):1246-1258.

122. Schwarz KB. “More Lessons from the Taiwanese HBV Vaccine Program” Journal of

Infectious Diseases January 19, 2012; doi:10.1093.

123. Roy A, Wang C, Li C, Lu L, Hagedorn C, Schwarz KB. Phenotypic and Genotypic Differences

between a child with vertically acquired severe hepatitis C liver disease and his mother. J

Pediatr Gastroenterol Nutr. 2012 Apr;54(4):567-9.

124. Hourigan SK, Anders RA, Mitchell SE, Schwarz KB, Lau H. Karnsakul W .Chronic diarrhea,

ascites, and protein-losing enteropathy in an infant with hepatic venous outflow obstruction

after liver transplantation. Pediatr Transplant. 2012 Apr 10.doi: 10.1111j.1399-

3046.2012.01686.x [Epub ahead of print]

125. Lucas J, Thompson JW, Dubois L, McCarthy J, Tillman H, Thompson A, Shire N, Hendrickson

R, Diegues F, Goldman P, Schwarz KB, Patel K, McHutchinson J, Moseley MA. Metaprotein

expression modeling for label-free quantitative proteomics BNC Bioinformatics 2012, 13:74.

126. Imteyaz H, Karnsakul W, Levine MA, Burrows PE, Benson J, Hsu S, Schwarz KB. Unusual

case of hypothyroidism in an infant with hepatic hemangioma. J Pediatr Gastroenterol Nutr.

2012 May;54(5):692-5.

127. Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Rosenthal P, Narkewicz MR, Roberts EA,

Schwarz KB. North American Society for Pediatric Gastroenterology, Hepatology and

Nutrition Practice Guidelines: Diagnosis and Management of Hepatitis C Infection in Infants,

Children and Adoloescents”. J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):838-55.

128. Jonas M, Balistreri W, Gonzalez-Peralta RP, Haber B, Lobritto S, Mohan P, Molleston JP,

Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB, Barton BA, Shepherd JA, Mitchell PD,

Duggan C. Peginterferon for Chronic Hepatitis C in Children Affects Growth and Body

Composition: Results from the Pediatric Study of Hepatitis C (PEDS-C) Trial. Hepatology.

2012 Aug;56(2):523-31.

-31-

129. Karnsakul W, Intihar K, Roy A, Colombani P, Schwarz KB. Living donor liver transplantation

in children: A single North American center experience over two decades. Pediatr Transplant.

2012 Aug;16(5):486-95. doi: 10.1111/j.1399-3046.2012.01725.

130. Squires R, Schwarz KB, Alonso E, Narkewicz M, Rodriquez-Baez N, Karpen S, Bucuvalas J,

Lobritto S, Rand ZL, Rosenthal P, Horslen S, Subbarou G, Kerkar N, Rudnick D, Romero, R,

Elifson S, Doo E, Lawlor S, Belle S. Intravenous N-acetylcysteine in Pediatric Patients with

Non-Acetaminophen Acute Liver Failure: A Placebo-Controlled Clinical Trial. Hepatology

In Press 2012 Aug 10. Doi:10.1002/hep. 26001 [Epub ahead of print]

131. Shneider B, Magee J, Karpen S, Rosenthal P, Schwarz KB, Kernar N, et al. “Cross-sectional

Multi-center Analysis of Portal Hypertension in 163 Children and Young adults with Biliary

Atresia”. J Pediatr Gastroenterol Nutr. 2012 Nov;55(5):567-73. doi:

10.1097/MPG.0b013e31826eb0cf.

132. Wolfe J, Anders R, Reddoch S, Schwarz KB, Savage W. Longitudinal Changes in Liver

Fibrosis in Children with Sickle Cell Disease Undergoing Chronic Transfusion Therapy. Acta

Gastroenterol Belg. 2012 Dec;75(4):419-24 .

133. Mogul D, Schwarz KB. Managing Children Infected with Hepatitis C Virus. Clinical Liver

Disease In press 2012.

134. Bennett J, Swanson PD, Hahn S, Schwarz KB. An exceptional family with three consecutive

generations affected by Wilson Disease. JIMD Rep. 2013;10:1-4. doi: 10.1007/8904_2012_206.

Epub 2013 Feb 7.

135. Molleston JP, Mellman W, Narkewicz MR, Balistreri WF, Gonzales-Peralta RP, Jonas MM,

Schwarz KB, et al. Assessment of Auto-antibodies and Their Relationship to Autoimmune

Disease during Treatment for Hepatitis C in Children. J Pediatr Gastroenterol Nutr. 2013

Mar;56(3):304-10. doi: 10.1097/MPG.0b013e3182774cae.

136. Roy A, Lieb W, Garrett B, Hodik M, Klipsch A, Young M, Barton B, Schwarz KB.

Recruitment and retention strategies in a clinical trial for children with chronic hepatitis C

infection. J Pediatr Nurs. 2013 May-Jun;28(3):243-8. doi: 10.1016/j.pedn.2012.08.006. Epub

2012 Sep 18.

137. Schwarz KB, Haber BH, Rosenthal P, Mack CL, Moore J, Bove K, Bezerra JA, Karpen SJ,

Kerkar N, Shneider BL, Turmelle YP, Whitington PF, Molleston JP,Murray KF, Ng VL,

Romero R, Wang KS, Sokol RJ, Magee JC; Childhood Liver Disease Research and Education

Network. Extra-hepatic anomalies in infants with biliary atresia: results of a large prospective

North American multi-center study. Hepatology 2013 Nov;58(5):1724-31.

138. Abbas MI, Oliva-Hemker M, Choi J, Lustik M, Gilger MA, Noel RA, Schwarz KB, Nylund

CM. Magnet Ingestions In Children Presenting to US Emergency Departments, 2002-2011.

JPGN 2013257(1)8-22.

-32-

139. Mohan P, Barton BA, Narkiewicz M, Molleston JP, Gonzalez-Peralta RP, Rosenthal P, Murray

KF, Haber B, Schwarz KB, Goodman ZD. Evaluating progression of liver disease from repeat

liver biopsies in children with chronic hepatitis C – a retrospective study. Hepatology 2013

Nov;58(5):1580-6.

140. Gurda GT, Zhu Q, Bai H, Devadason A, Pan D, Schwarz KB, Anders RA. The utility of Yes-

associated protein (YAP) expression in the diagnosis of persistent neonatal cholestatic liver

disease. Hum Pathol. 2014 May;45(5):1057-64.

141. Lin HC. Alvarez L, Laroche G, Melin-Aldana H, Pfeifer K, Schwarz KB, Whitington P,

Alonso EM, and Ekong UD. Rituximab as Therapy for Recurrence of Bile Salt Export Pump

Deficiency after Liver Transplantation. Liver Transplantation In press 2013.

142. Leonis MA, Alonso EM, Im K, Belle SH, Schwarz KB, Squires RH; Pediatric Acute Liver

Failure Study Group. Chronic acetaminophen exposure in pediatric acute liver failure.

Pediatrics. 2013 Mar;131(3):e740-6.

143. Roy A, Lieb W, Garrett B, Hodik M, Klipsch A, Young M, Barton B, Schwarz KB.

Recruitment and retention strategies in a clinical trial for children with chronic hepatitis C

infection. J Pediatr Nurs. 2013 May-Jun;28(3):243-8.

144. Alonzo EM, Martz K, Wang D, Yi MS, Neighbors K, Varni JW, Bucuvaloas JC; Schwarz KB.

Studies of Pediatric Liver Transplantation (SPLIT) Functional Outcomes Group (FOG). Pediatr

Transplant. 2013 Nov;17(7):605-11.

145. Gregorz G, Schwarz KB, Zhu Q, Bai H, Pan D, Anders, R, Devadason, A. Expression of the

Yes-associated protein (YAP) in persistent neonatal cholestatic liver disease. Human Pathology

2014 In press.

146. Sue PK, Pisanic N, Heaney C, Nelson K, Schwarz KB, Forman, M, Valsamakis A, Karnsakul

W. Variability of Hepatitis E serologic assays in a 4 year old liver transplant recipient:

Challenges to diagnosing Hepatitis E Virus infection in the United States. 2014

147. Schwarz KB , Molleston JP, Jonas MM, Wen J , Murray KF, Rosenthal P, Gonzalez-Peralta, R,

Lobritto S, Mogul D, Hooper G, Warne C, and Thompson B. Long-Term Growth Outcomes in

Children Treated for Chronic Hepatitis C in the PEDS-C Trial. In Press J Pediatrics 2014.

148. Bezerra JA, Spino C, Magee JC, Shneider BL, Roenthal P, Wang KS, Erlichman J, Haber B,

Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston JP, Romero R, Schwarz KB, et al.

Childhood Liver Disease Research and Education Network (ChiLDREN). Use of

corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia:

the START randomized clinical trial. JAMA. 2014 7;311(17):1750-9.

149. Koeck E, Mohan P, Iordanskaia T, Rossi C, Schwarz KB. Integrin Beta-8, but not Beta-5 or -6,

Protein Expression is Increased in Livers of Children with Biliary Atresia. JPGN Submitted

2014.

-33-

150. Iordanskaia T, Hubal MJ, Koeck E, Rossi C, Schwarz K, Nadler EP. Dysregulation of upstream

and downstream transforming growth factor-β transcripts in livers of children with biliary

atresia and fibrogenic gene signatures. J Pediatr Surg. 2013 Oct;48(10):2047-53.

151. Nadler E, Iordanskaia T, Rossi C, Mohan P, Anders R, Schwarz, KB. JPGN-14-365R1:

“Integrin Beta A-8, but not Beta A-5 or -6, Protein Expression is increased in livers of children

with Biliary Atresia”. JPGN 2014 Dec;59(6):679-83.

152. Shores DR, Bullard JE, Aucott SW, Stewart FD, Haney C, Nonyane BAS, Schwarz KB.

Incidence of Parenteral Nutrition-Associated Liver Disease and Enteral Feeding Practices

Among Infants with Bowel Resection. ICAN In Press 2014.

153. Ng VL, Haber BH, Magee JC, Miethke A, Murray KF, Michail S, Karpen SJ, Kerkar N,

Molleston JP, Romero R, Rosenthal P, Schwarz KB, Shneider BL, Turmelle YP, Alonso EM,

Sherker AH, Sokol RJ; Childhood Liver Disease Research and Education Network

(CHiLDREN. Medical status of 219 children with biliary atresia surviving long-term with their

native livers: results from a North American multicenter consortium. J Pediatr. 2014

Sep;165(3):539-546.e2. doi: 10.1016/j.jpeds.2014.05.038. Epub 2014 Jul 9.PMID:25015575.

154. Schwarz KB, Olio DD, Lobritto SJ, Lopez MJ, Rodriguez-Baez N, Yazigi NA, Belle SH, Zhang

S, Squires RH; for the Pediatric Acute Liver Failure Study Group (PALFSG). An Analysis of

Viral Testing in non-Acetaminophen (non-APAP) Pediatric Acute Liver Failure (PALF). J

Pediatr Gastroenterol Nutr. 2014 Jul 24. [Epub ahead of print]PMID:25079486.

155. Clemente MG, Patton JT, Yolken R, Whitington PF, Parashar UD, Jiang B, Raghunathan TR,

Schwarz KB, and the Childhood Liver Disease Research and Education Network. Prevalence

of Groups A and C Rotavirus Antibodies in Infants with Biliary Atresia and Cholestatic

Controls. Submitted J Pediatr 2014.

156. Jonas MM, Schwarz KB, Gonzalez-Peralta R, Lobritto S, Molleston JP, Murray KF, Rosenthal

P, Wen J, Wat C, Pavlovic V and Warne C. Long-Term Growth Outcomes in Children Treated

for Chronic Hepatitis C. J Pediatr 2014.

157. Karnsakul W, Schwarz KB. Hepatitis in Remington & Klein: Infectious Disease of the Fetus

and Newborn Child, 8th edition. Elsevier, 2014 (in press).

158. Karnsakul W, Schwarz KB. Autoimmune hepatitis in: McMillan, Barrett, Boney, and Jones

(ed.) Clinical Decision Support digital program on Pediatrics, first edition, 2014.

159. Karnsakul W, Schwarz KB. Viral hepatitis in: McMillan, Barrett, Boney, and Jones (ed.)

Clinical Decision Support digital program on Pediatrics, first edition, 2014

-34-

160. Sue PK, Pisanic N, Heaney CD, Mixson-Hayden T, Kamili S, Nelson K, Schwarz KB, Forman

M, Valsamakis A, Karnsakul W, Ticehurst J. Variability of hepatitis E serologic assays in a

pediatric liver transplant recipient: challenges to diagnosing hepatitis E virus infection in the

United States. Transpl Infect Dis. 2015 Feb 4 doi: 10.1111/tid.12366. [Epub ahead of print]

PMID: 25648626 [PubMed – as supplied by publisher]

XIII. BOOK CHAPTERS (AND NON-REFERRED PUBLICATIONS)

1. Schwarz, KB and Olson RE. Ch. 49. Requirements and Absorption of Fat-Soluble Vitamins

During Infancy in Lebenthal, E. (ed.). Textbook of Gastroenterology and Nutrition in Infancy

Vol 2. Raven Press, New York, 1981.

2. Schwarz, KB, Vitamins in Modern Day Society (Chapter) in Walker WA and Watkins J,

(editors), Nutrition in Pediatrics ? Basic Sciences and Clinical Applications. Little, Brown and

Company, Boston, Massachusetts 1985.

3. Schwarz, KB, Requirements and Absorption of the Fat Soluble Vitamins During Infancy in

Lebenthal, E. (Ed) Textbook of Gastroenterology and Nutrition in Infancy. Raven Press, New

York 1989.

4. Schwarz, KB, The Child With Abdominal Pain: Psyche or Soma? Practical Gastroenterology,

1989, 13(8):65-73.

5. Perman JA and Schwarz, KB. Hepatitis, in Primary Pediatric Care eds. Hockelman, Friedman,

Nelson, and Seidel. Mosby Year Book, Baltimore, MD 1992.

6. Ramos A and Schwarz, KB. Recent Advances in the Hepatitides. Gastroenterology Clinics of

North America 1994. Pediatric Gastroenterology, Part I, 1994; 23:753-768.

7. Perman JA and Schwarz, KB. Hepatitis - in Hoeklman et al. Primary Pediatric Care 1994,

Mosby Year Book Inc. Baltim5. Perman JA and Schwarz, KB. Hepatitis, in Primary

Pediatric Care eds. Hockelman, Friedman, Nelson, and Seidel. Mosby Year Book, Baltimore,

MD 1992.

6. Ramos A and Schwarz, KB. Recent Advances in the Hepatitides. Gastroenterology Clinics of

North America 1994. Pediatric Gastroenterology, Part I, 1994; 23:753-768.

7. Perman JA and Schwarz, KB. Hepatitis - in Hoeklman et al. Primary Pediatric Care

1994, Mosby Year Book Inc. ore, MD 1994.

-35-

8. Ciguerroa, Schwarz, KB, and Colombani PM. Biliary Atresia. Surgery of Infants in

Children: Scientific Principles and Practice. Published by JB Lippincott Co. (in press

1994)

9. Schwarz KB. Vitamins (Chapter) edited by Walker WA and Watkins J. Nutrition in

Pediatrics - Basic Sciences and Clinical Applications. Publisher B.C. Decker Inc.

Hamilton.London 1996;8:115-135.

10. Perman JA and Schwarz, KB. Hepatitis in Primary Pediatric Care eds. Hockelman,

Friedman, Nelson, and Seidel. Mosby Year Book, Baltimore, MD 1997.

11. Zellos A and Schwarz KB. Congenital and Structural Abnormalities of the Liver In: D.A.

Kelly, editor. Diseases of the Liver and the Biliary System in Children. Oxford, U.K:

Blackwell Science 1999: 124-140.

12. Zellos A and Schwarz KB. Hepatitis C in Children, Contemporary Pediatrics 1998;15(4):

39-58.

13. Sokol RJ and Schwarz KB. Recommendations for Management of Liver and Biliary

Diseases in Cystic Fibrosis. J Pediatr Gastroenterol Nutr 1999;28 (Suppl. 1):S1-S13.

14. Schwarz KB. Nutritional Issues for Patients with Cholestatic Liver Disease. Nutrition

and the MD. In press 2000.

15. Schwarz, KB. Portal hypertension in Howard, Stringer, & Colombani eds: Surgery of the

Liver, bile- ducts and pancreas in children. Second edition Arnold (Publishers Limited)

London, England. In Press 2001

16. Schwarz KB, Rigby, S . Nutrition Prevention and Treatment of Disease: Nutrition and

Liver Disease . Academic Press, Inc. In Press 2001

17. Schwarz, KB. Review: Pediatric Issues In New Therapies for Hepatitis B and C.

Current Gastroenterology Reports 2003, 5(3):233-9.

18. Li DY, Schwarz KB: Congenital and structural abnormalities of the liver. In: Kelly

D (eds), Disease of the Liver and Biliary system in Childhood, 2nd

edition, pp 162-182

2003, Blackwell Publishing.

19. LI, DY, Schwarz KB. Autoimmune Hepatitis in Adolescent Medicine Clinics -

Gastrointestinal Disorders in Adolescents - edit by J.S. Hyams 15(1): 131-43, 2004.

20. Schwarz KB. Viral Hepatitis in Children. In Advanced Therapy in Gastroenterology

and Liver Disease. 5th Edition Eds Theodore Bayless and Anna Mae Diehl

108:625-628:2005; B.C. Decker, Inc.

21. Cabellero B. ed. Encyclopedia of Human Nutrition 2e Ch 180: Hampsey J and Schwarz

-36-

KB. Liver disorders: Nutritional Management in press 2005. Encyclopedia of Human

Nutrition, Second Edition, Editors: B Caballero, L Allen and A Prentice. 2005

Elsevier Ltd. ISBN (Set): 0-12-150110-8

22. Hardikar W, Schwarz KB. Hepatitis Chapter 216, in: McInerny TK, Adam HM,

Campbell D, Kamat DK, Kelleher KJ, eds. Pediatric Primary Care 5th

Ed. Elk Grove

Village, IL: American Academy of Pediatrics; In press.2006

23. Sullivan S, Schwarz KB. Water-Soluble Vitamins. Chapter for the 6th

Edition

Of the AAP Nutrition Handbook. In Press 2006

24 Roy A, Schwarz KB, Hepatitis C in Children. Chapter, Hepatitis C Choices, 4th

Edition

Publisher In press 2006 –

25. Schwarz KB. Viral Infection and Oxidative Stress. Invited Review Rivista di Immuno

In preparation

26. Karnsakul W, Schwarz KB. Hepatitis in Remington & Klein: Infectious Disease of the

Fetus and Newborn Child, 7th edition. Elsevier, (In Press) 2009.

27. Clemente MG, Schwarz KB. Hepatitis. General Principles, Pediatrics in Review

2011;32,333.

28. Schwarz KB. Hepatitis C – Not So Indolent in Survivors of Pediatric Cancer?

Highlight/Invited Commentary on “An updated follow-up of chronic hepatitis C after

three decades of observation in pediatric patients by Cesaro et al in Pediatric Blood and

Cancer July 15 2010:55(1) 108-112.

29. Schwarz KB. HCV and the Pediatric Population Advanced Therapy for Hepatitis C,

Edited by Geoff McCaughan, John McHutchison and Jean-Michel Pawlotsky. Wiley-

Blackwell Books. First Edition Chapter 24 p190-195 2012 Blackwell Publishing Ltd.

30. Clemente MG, Schwarz KB. Hepatitis: General Principles, Pediatrics in Review

2011;32;333.

31. Mogul D, Schwarz KB. Curbside Consultation in Pediatric GI: 49 Clinical Questions

2012.

32. Schwarz KB. Management of Chronic Hepatitis B and C Virus Infection in Children: A

2011 Update. Journal of Pediatr Gastro Nurt 54 (1): May 1, 2012.

33. Schwarz KB. From Bilirubin to Biologics: a History of the Johns Hopkins Division of

Pediatric Gastroenterology in Winklestein, J – a History of the Johns Hopkins Childrens

Center In Press 2013.

34. Mogul D and Schwarz KB. Managing Children Infected with Hepatitis C Virus.2013.

-37-

JID J_ID: CLD64 Date: 27-June-12 Page: 1

35. Imteyaz H, Karnsakul W, Levine MA, Burrows PE, Benson J, Hsu S, and Schwarz

Kathleen B. An Unusual Case of Hypothyroidism. Clinical Problem Solving

36. Schwarz Kathleen B Idiopathic Neonatal Hepatitis and Congenital Infections. Chapter in

Murray KM and Horslen S. Childhood Liver Diseases. In press 2013

37. Karnsakul and Schwarz KB. Metabolic Disorders in the Older Child. Chapter in Sibal A.

Pediatric Gastroenterology, Hepatology, and Nutrition. In Press 2013

XIV. PUBLISHED ABSTRACTS

1. Schwarz KB, Alpers DH and Karl I, Ammonia metabolism by isolated perfusion ileum.

Gastro 72:A105/1128, 1977 (Presented to the American Gastroenterology Association,

April, 1977, Toronto, Canada).

2. Schwarz KB, Zimmerman DC, Zahn M, Alpers DM and Avioli LV, Mechanism for sex

differences in antacidinduced phosphate depletion (abstract). (Proceedings of the Annual

Meeting of the Midwest Society for Pediatric Research - October 30-31, 1979,

Cincinnati, Ohio).

3. Schwarz KB, Witztum J, Schonfeld G and Grundy S, Influence of age on cholesterol

synthesis in children with homozygous familial hypercholesterolemia (HCH). (Midwest

Society for Pediatric Research, November, 1978, Chicago, IL). J Pediatr 96:160, 1980.

4. Schwarz KB, Ternberg JL, Bell MJ, Keating S, and Keating JP, Sodium balance in the

infant ileostomate. (Presented at the Society for Pediatric Research, San Francisco,

4/29/81 Poster Session). #635 Pediatr Res 1981;15:546.

5. Schwarz KB, Karl IE, and Alpers DH, Effect of intraluminal cation exchange resin on

excretion of ammonia in rat ileum. San Francisco, #634 Pediatr Res 1981;15:546.

6. Schwarz KB, Zimmerman DC, Zahn M, Alpers DH, and Avioli LV, Mechanisms for sex

differences in antacid-induced phosphate depletion. San Francisco, #636 Pediatr Res

1981;15:546.

7. Schwarz KB, Gurevitz M, and Karl IE, Hypophosphatemia in Reye's Syndrome. Pediatr

Res 1981;65:33.

8. Gurevitz M, Schulze I, deMello E, and Schwarz KB, Reye's Syndrome model in rats with

phosphorus (P4). Pediatr Res 1982;16:164A.

-38-

9. Squires JE, Keating JP, Schwarz KB, Squires RH, Haymond MW, Devivo DC, and

Rodey G, HLA phenotypes in Reye's Syndrome patients. Pediatr Res 1982;16:178A.

10. Schwarz KB, Gurevitz M, Kanjanajjulpan P, Ylagan M, Schonfeld G, and Fitch CD,

Decreased plasma vitamin E suggests role for hepatic lipid peroxidation in Reye's

Syndrome. Pediatr Res 1983;17:200A.

11. Gurevitz M, Schulze I, Swierkosz E, and Schwarz KB, Altered phosphate metabolism as

a possible link between influenza virus infection and Reye's Syndrome: Effect of

influenza virus on phosphate uptake in epithelial cell culture. Pediatr Res 1983;17:217A.

12. Coyne WH, Erickson SM, Ylagan M, and Schwarz KB, Nutritional assessment in infants

with diarrhea. Pediatr Res 1993;17:186A.

13. Schwarz KB, Keating JP, Kanjananggulpan P, and Fitch CD, Altered erythrocyte

malondialdehyde (RBC/MDA) formation in Reye's Syndrome. Clin Res 1984;32:810A.

14. Schwarz KB, and Bracamontes J, Erythrocyte malondialdehyde (RBC-MDA) formation

during hepatic lipid peroxidation. Hepatology 1984;4:1062.

15. Schwarz KB, Larroya S, Kohlman L and Morrison A. Increased erythrocyte phospholipid

arachidonic acid in Reye's Syndrome (RS). Clin Res 1985;33:A906.

16. Mahanty S, and Schwarz KB. Possible pro-oxidants in hepatic microsomes from a

mouse model of Reye's Syndrome. Hepatology 1985;5:1012.

17. Schwarz KB, Larroya S, Kohlman L, and Morrison A, Increased erythrocyte

phospholipid arachidonic acid in Reye's Syndrome. Pediatr Res 1986;20:334A.

18. Mahanty S, Arey B, and Schwarz KB Aspirin stimulates malondialdehyde production in

mouse liver microsomes. Pediatr Res 1986;20:244A.

19. Schwarz KB, Arey BJ, and Mahanty S. Iron chelation by aspirin (ASA) as a possible

mechanism for ASA-induced malondialdehyde (MDA) production in mouse liver

microsomes. Hepatology 1986;6:1228.

20. Sippel CJ, Cockrell R, and Schwarz KB Influenza virus alters hepatic mitochondrial

oxygen consumption utilizing electron transferring dyes in a mouse model of Reye's

syndrome. Pediatr Res 1987;21:277A.

21. Larroya S, and Schwarz KB Influenza virus alters hepatic mitochondrial lipids in a mouse

model of Reye's Syndrome. Pediatr Res 1987;21:271A.

22. Schwarz KB and Vogler C. Effect of virus preparation on hepatic histopathology in

influenza B virus-treated mice. Ped Res 1998;23:312A.

-39-

23. Shah MC, Weber TR, Connors RR, Hermann VM, Stockmann SM, and Schwarz KB

Nitrogen balance in newborns treated with extra corporeal membrane oxygenation

(ECMO) Pediatr Res 1988;23:313A.

24. Schwarz KB. Effect of iron and desferrioxamine on malondialdehyde production in Hep

G2 cells. Hepatology; 1988;639.

25. Schwarz KB and Seligman P. Effect of Influenza B Virus on Fe-transferrin Uptake by

Hep G2 Cells. Gastroenterology 1989;96:A658.

26. Schwarz KB, Moore TJ, Willoughby RE, and Yolken RH. Growth of Rotaviruses in a

Human Liver Cell Line. Society for Pediatr Res, 1989;25:728.

27. Schwarz KB, Moore TJ, Willoughby RE, and Yolken R. Hep G2 Cells Support

Rotavirus Infection. Hepatology 1989;9: October.

28. Refat M, Moore TJ, Perman JA, and Schwarz KB. Breath Ethane as a Noninvasive

Biomarker of Vitamin E Status in Children. Hepatology, 1990;12;369.

29. Schwarz KB and Korba B. Desferrioxamine (DF) inhibits hepatitis B virus (HBV) virion

production by Hep G2(2.2.15) cells. Hepatology 1990;12:540.

30. Schwarz KB, Beharens P, and Korba B. Inhibition of hepatitis B virus replication in

2.2.15 cells by two different microalgal extracts. Hepatology 1991;14;4:278.

31. Schwarz KB, Moore TJ, Clemens MD, and Seligman P. Influenza B virus promotes lipid

peroxidation (LP) in Hep G2 cells via effects on iron metabolism. Hepatology

1991;14;4:335.

32. Schwarz KB, Cox JM, Sharma SA, Clements L, Humphrey JR, and Witter FA.

Deficiencies of multiple antioxidant nutrients in inner city pregnant women despite

alleged intake of prenatal vitamins. Pediatr Res 1992;31.

33. Schwarz KB, Cox JM, Sharma SA, Witter FA, Perman JA, Sehnert SS, and Risby TH.

Dietary fat intake and serum carotene correlate positively with breath ethane during

pregnancy. Pediatr Res 1992;31:295A.

34. O'Gorman MA, Sharma S, Tennant BC, Gerin JL, Groopman JD, and Schwarz, KB.

Lipid peroxidation and oxidative DNA damage in woodchuck hepatitis virus (WHV) -

infected hepatocytes. Presented AASLD & NASPGN Chicago IL, November 1992,

Hepatology 1992;16;2:159A.

35. Cox JM, Wilhelm J, Machado AA, and Schwarz, KB. Selenium deficiency in children

with chronic liver disease. Hepatology 1992;16;2:79A.

-40-

36. Schwarz, KB, McCaskill QE, Cox JM, and Risby TH. Utility of breath pentane as a

non-invasive index of liver function in children. Presented NASPGN Nov, 1992,

Chicago IL, Hepatology 1992;16;2:237A.

37. Schwarz, KB, Xoc JM, Sharma S, Witter F, Perman JA, Sehnert S, and Risby TH.

Elevation of breath ethane in pregnant women who smoke. Presented Society for

Pediatric Research, Washington, DC, May, 1993, and International Conference on

Critical Aspects of Free Radicals in Chemistry, Biochemistry, and Medicine, Vienna,

Australia, February, 1993.

38. Schwarz, KB, Moore TJ, Sharma S, Lederman H. Aspirin, influenza B virus, and

endotoxin-activated macrophages depress mitochondrial respiration in Hep G2 cells.

Hepatology 1993; 18;4:332A.

39. O'Gorman MA, Fivush BA, Colombani PM, Burdick JF, Schwarz, KB. Proximal renal

tubular acidosis secondary to FK506. Hepatology 1993;18;4:339A.

40. Ramos AG, Mitchell SE, Colombani PM, Schwarz, KB. Severe gastrointestinal bleeding

(GIB) post liver transplantation (LT) in infants. Hepatology 1993;18;4:1139A.

41. Rosensweig J, Sharma S, Schwarz, KB. Lipid emulsion stimulates collagen synthesis in

3T3 Fibroblasts. Mead Johnson Pediatric Gastroenterology Fellows Symposium. Fort

Lauderdale FL 1994.1

42. Yokois NU, Perlman EJ, Colombani P, Wise B and Schwarz, KB. An Atypical

Presentation of Kaposi Sarcoma In An Adolescent Orthotopic Liver Transplant Patient. J

Pediatr Gastr Nutr 1995;21(3):356.

43. Rosensweig J, Rosenstein B and Schwarz KB. Plasma Transforming Growth Factor Beta

1 (TGFß1) Is Reduced In Cystic Fibrosis (CF) Liver Disease (CFLD) But Elevated In

Advanced CF Pulmonary Disease (CFPD). J Pediatr Gastro Nutr. 1995; 21(3):360.

44. Schwarz KB, Hesterberg L, Boitnott J, Casella J and Dover G. Safety and Utility of

Percutaneous Liver Biopsy (PLB) in Hemophiliac Children with Hepatitis C(HCV).

Hepatology 1995; 22(4):276A.

45. Ogburn P, Kanayama M, Van Winter, J, Holman R, and Schwarz, KB. Changes in

Circulating Long Chain Essential Fatty Acids (LCEFA) in Normal Human Pregnancy.

Am J Obstet Gynecol 1996;174(1):375.

46. Schwarz KB, Sharma S, Sitzman J, Klein A, Yager J, Abrams R, Kew M and Groopman

J. Role of Oxidative DNA Damage in Hepatitis B Virus (HBV) Hepatocarcinogenesis.

Hepatology 1996;24(4):469A.

47. Schwarz KB, Sharma S, Cox J, Isola J, Hill K, and Burk R. Decreased plasma

-41-

selenium and selenoprotein P in children with chronic liver disease. Hepatology.

Presented AASLD 1997

48. Schwarz KB, Stamato L, Sharma S, Casella J, Perlman E, Boitnott J and Thomas D.

Response to alpha-interferon(IFN) therapy in hemophiliac children(HC) with hepatitis

C(HCV). Hepatology 1997; 26(4): Pt. 2 419A.

49. Zellos A, Thomas D, Perlman J, Boitnott J and Schwarz KB. Liver pathology in a

cohort of hepatitis C virus (HCV) infected children. J Pediatr Gastroenterol Nutr

1998;26 (5):A202. Poster presentation in the ESPGHAN-NASPGN 5th

Joint Meeting: Toulouse, France, May 1998.

50. Zellos A, Thomas D, Sharma S, Mocilnikar C, Stamato L, Perlman E, Boitnott J, Casella

J and Schwarz KB. Response to interferon alpha-2b therapy in children with hepatitis C

virus (HCV) infection. Acta Gastro-Enterologica Belgica 1998; 61(2):A253. Oral

presentation in AViral Hepatitis throughout Infancy to Adulthood@ Meeting: Brussels,

Belgium, May 1998.

51. Flinn IW, Lemas MV, Noffsinger LE, Fabian D, Yang J, Krone C, Post L, Tran T,

Davis-Sproul LE, Wright S, Schwarz KB, Colombani PM, Orentas RJ, Noga SJ and

Ambinder RF. Phase I dose-escalation trial of partially-matched and haploidential EBV

cytotoxic T lymphocytes in patients with EBV malignancies. 8th International Meeting

of the EVC-Association in Stockholm, Sweden, June 12-16, 1998.

52. Zellos A, Thomas D, Boitnott J, Perlman E, Casella J and Schwarz KB. High viral load

and mild liver injury in young hemophiliacs compared to other children with hepatitis C

virus (HCV) infection. Hepatology 1998; 28(4):A796.

Poster presentation at the AASLD Meeting, Chicago, October 1998.

53. Prabhakaran BA, Lau HT, Wise B, Schwarz KB and Colombani, PM. Incidence of

allergic symptoms in pediatric liver transplant recipients treated with tacrolimus based

immunosuppression. Presented 1999 Surgical Section of American Academy of

Pediatrics.

54. Zellos A, Mocnilkar C and Schwarz KB. Autoimmune hepatitis in patients with

preexisting liver disease. (NASPGN, Denver, Co October 1999).

55. Cohen M, Wise B, Stamato L, Colombani P and Schwarz KB. Utility of liver biopsy

culture in pediatric liver transplant recipients. (NASPGN 1999).

56. Darbari A, Schwarz KB, and Sabin K. Epidemiology of primary and secondary hepatic

malignancies in U.S. children, 1975-1996. (NASPGN 1999)

57. Zellos A, de Almeida A, Karp CL, Jones L, Thomas Dl and Schwarz KB. Decreased

interleukin-2 and interleukin-4 secretion in children with hemophilia and hepatitis C virus

infection. (AASLD 1999).

-42-

58. Darbari A, Sabin KM, Shapiro CW and Schwarz KB. Epidemiology of primary hepatic

Malignancies in U.S. Children1973-1996. Hepatology 1999; 30(4)2:71A.

59. Schwarz KB, Kew MC, Klein AS, Abrams RA, Sitzmann JV, Jones L, Sharma S, Bacon

BR, Di Bisceglie AM, Groopman JD. Increased hepatic oxidative DNA damage in

patients with hepatocellular carcinoma. (AASLD 1999) Dig Dis Sci 2001;46(10):2173-8.

60. Darbari A, Schwarz KB, Sabin K. Epidemiology of hepatocellular carcinoma in U.S.

children, 1973-1996. (AASLD 1999).

61. Flinn IW, Lemas MV, Yang J, Murray PG, Post L, Eby L, Fabian D, Noga S, Mann RB,

Krone C, Ma H, Cottler-Fox M, Schwarz KB, Colombani P, Orentas RJ and Ambinder

RF. EBV adoptive T cell therapy with partially HLA-matched donors is not associated

with graft-versus-host disease (GVHD), American Society of Hematology 1999.

62. Jacobson KR, Murray KF, Zellos A, Schwarz KB. Analysis of interferon

monotherapy trials in children with HCV. World Congress August 5-9, 2000

Boston, MA. J Pediatr Gastroenterol Nutr. 2002;34(1):52-8.

63. Zellos A, DeAlmeida A, Karp CL, Jones L, Hollomon E, Casella JF, Schwarz KB.

Decreased interleukin-12 secretion in children with hemophilia and Hepatitis C virus

infection. Hepatology 51st Annual Meeting, 32:284A 2000.

64. Darbari A, Kan J, Cameron D, Sena L, Schwarz KB. Utility of cardiac angiography

during upper gastrointestinal endoscopy to diagnose "pseudo vascular ring". World

Congress - August 5-9, 2000, Boston, MA.

65. Colombani PM, Prabhakaran K, Wise B, Lau HT, Schwarz K. Incidence of allergic

symptoms in pediatric liver transplant recipients treated with tacrolimus based

Immunosuppression. First Congress of the International Transplant Association,

Venice, Italy, August 23-25, 2000.

66. Colombani PM, Prabhakaran K, Schwarz K, Wise B, Lau HT. Comprehensive

prospective management of biliary atresia. First Congress of the International

Transplant Association, Venice Italy, August 23-25, 2000

67. Schwarz KB, Alford MK, Barker PB. Utility of proton magnetic resonance spectrostocpy

(PMRS) in children with liver failure. Poster presentation AASLD, Dallas Texas, November

2001

68. Li DY, Oelke M, Schneck J, Schwarz KB. Generation of HCV peptide-specific CD8+ cytotoxic

T lymphocytes and their visualization by a divalent peptide-HLA A2-lg complex. Poster

presentation AASLD, Dallas Texas, November 2001.

-43-

69. Schwarz KB, Sztam K, Zellos A, Alford MK. Epidemiology of chronic hepatitis C virus (HCV)

infection in children born after 1990 and referred to a university clinic. AASLD Dallas, Texas,

November 2001. To be published Hepatology October 2001.

70. Schwarz KB, Ichord RN, Reimschisel TY, Alford MK, Barnes YP, Pulsifer M.

Neuropsychological profiles of children with end-stage liver disease (ESLD) pre-and post

transplant. AASLD, Dallas Texas, November 2001. To be published Hepatology, October 2001.

71. Schwarz KB, Rosensweig S, Sharma S, Jones L, Durant M, Potter C and Narkewicz MR.

Increased plasma transforming growth factor beta 1 in patients with severe pulmonary disease

secondary to cystic fibrosis. Poster presentation 14th

annual NASPGN meeting, Orlando

Florida, October 2001.

72. Li DY, Boitnott JK, and Schwarz KB. Human herpes virus-6 (HHV-6): cause of fulminant

hepatic failure or “innocent bystander”. Poster presentation 14th

NASPGN Annual meeting,

Orlando Florida, October 2001.

73. Albayram F, Stone K, Nagey D, Schwarz KB, Blakemore B. Alagille syndrome:

prenatal diagnosis and pregnancy outcome. Fetal Diag & Ther 2002;17(3):182-4.

74. Balistreri W, Schwarz KB. Viral Hepatitis. J Pediatric Gastroenterology and Nutrition

35:S29-S32 July 2002

75. Li DY, Scheimann A, Songer G, Horwitz M, Resar L, Schwarz KB. A rare case of

enteritis necroticans caused by clostriduium perfringens type C and recurrent

enterocutaneous fistula E in a child with cyclic neutropenia. Poster presentation

NASPGHAN 15th

Annual Meeting, San Antonio, Texas, October 2002.

76. Schwarz, KB, Mohan P, Narkewicz M, Molleston JP, Te HS, Hu S, Sheridan S, Lamb M,

Pappas SC and Harb G. The Safety, Efficacy and Pharmacokinetics of Peginterferon Alpha-2a

(40KD) In Children with Chronic Hepatitis C. Gastroenterology, April 2003 Vol

124(4) Suppl 1-Page A-700 DDW Orlando, Fla May 2003. Submitted JPGN 5/06

77. Oliva-Hemker M, Paidas C, Campbell A, Lindyberg K, Schwarz KB, Zambidiset E.

Malignant mesothelioma mimicking inflammatory bowel disease. J. Pediatr

Gastroenterol Nutr (In Press)

78. Li DY, Scheimann A, Songer G, Horowitz Ml, Resar L, Schwarz KB. A Rare Case of

Enteritis Necroticans Caused by Clostridium Perfringens Type C and Recurrent

Enterocutaneous Fistulae in a Child with Cyclic Neutropenia. NASPGHAN Annual

Meeting , San Antonio, Texas, October. 2002

79. Schwarz KB, Stover B Staples A, Barnes PY. Low HBV Vaccine Coverage of Homeless

Children in Baltimore: US Public Policy Implications? Hepatology 53rd

Annual Meeting,

Boston, Mass, 2002. Hepatology 36(4):Pt.2;368A Oct. 2002 .

-44-

80. Schwarz KB, Barnes, PY, Stover B, Bowser Y, Bareta J.Application of a Fingerstick Technique

to Survey Hepatitis C Virus (HCV) Epidemiology in Homeless Children and Their Caregivers in

Baltimore City. Hepatology Annual Meeting, Boston, Mass. November, 2002. Hepatology

36(4)Pt. 2, 565A; 2002.

81. Schwarz KB, Lee J, Stover B, Barnes PY, Bowser Y, Bareta J. Impact of a Culturally

Appropriate Educational Video on Acceptance of Hepatitis B Vaccine by Homeless Families. .

Hepatology Annual Meeting, Boston, Mass. Hepatology 36(4);Pt. 2:621A 2002.

82. Li DY, Byrnes A, Mocilnikar C, Schwarz, KB. The Magnitude of IFN-Driven IFN

Production Correlates with Sustained Hepatitis C Viral Clearance in Children Treated

with Pegylated IFN 2(40KD). NASPGHAN Annual Meeting, October 2-5, 2003,

Montreal, Quebec.

83. Castiglia, Schwarz KB. An Extended, Stratified, Follow-On Study in Children with

chronic Hepatitis B (CHB) Who Have Completed Previous Lamivudine Studies.

AASLD Annual Meeting, October 24-28 2003, Boston. HEPATOLOGY 38(4)Suppl 1, P 711A

2003.

84. Schwarz KB, Garrett BM, Barnes PY, Ashe S, Bowser YD and O’Driscoll P.

High Prevalence of Hepatitis C Virus (HCV) in Homeless Caregivers in Baltimore.

Presented at the 2nd

World Congress of Pediatric Gastroenterology, Hepatology and

Nutrition, July 2004, Paris, France.

85. Schwarz KB. Hepatitis C Viral Kinetics in Children Treated with PegIGN Alfa-2A

Presented AASLD on October 31, 2004

86. Schwarz KB. Inadequate Hepatitis B Vaccine Coverage in Older Homeless Children

In Baltimore. DDW Annual Meeting, New Orleans, LA 2004 Oral Presentation

World Congress of Pediatric Gastroenterology, Hepatology and Nutrition, Paris, France, July

2004.

87. Schwarz, KB. Cost Effectiveness of Living Related Liver Transplantation

AASLD Annual Meeting Boston, MASS 2004 Hepatology

88. Shneider B, Brown M, Sokol R, Whitington P, Schwarz K, Squires R, Shepherd R,

Rosenthal P, Robuck P, and BARC. A Multi-Center Analysis of Outcome at 24 Months

of Age in Children with Biliary ATresia in the United States. Presented at the American

Association for the Study of Liver Diseases, 55th

Annual Meeting, Boston, MA Hepatology

2004 Oct;40(S4):201A.

89. Schwarz KB, Garrett B. “ High Prevalence of Obesity in Homeless Baltimore Children and

their Caregivers” Poster Presentation at Annual NASPGHAN Meeting, Salt Lake City, UT

October , 2005.

-45-

90. Murray KF, Barton B, Gonzalez-Peralta RP, Rodrigue J, Shepherd J, Schwarz, KB.

Development of a Large Scale Multi-Center Randomized Center Trial of Children with

Chronic Hepatitis C Virus Infection PEDS C. NASPGHAN Meeting, Salt Lake City, UT

October, 2005. JPGN 41(4) October 2005 p 524.

91. Sullivan, S, Schwarz KB. Management of a Type III Choledochal Cyst. Poster

Presentation at NASPGHAN Meeting, Orlando City, FL. October 19-22, 2006.

92. Schwarz KB. “Positive Impact of Hepatitis B(HB) Video on HB Vaccine Coverage in

Homeless Children and Adolescents in Baltimore: Results of a Randomized Controlled Trial”

Abstract/Poster Presentation AASLD 57th

Annual Meeting – Boston, MA Oct. 27-31, 2006

93. Goodman Z, Makhlouf H, Liu L, Balistreri W, Gonzalez-Peralta R, Haber B, Jonas M, Mohan

P, Molleston J, Murray K, Narkewicz M. Rosenthal P, Smith L, Schwarz KB. Pathology of

Chronic Hepatitis C in Children: Liver biopsy findings in the PEDS C Trial. Abstract/Poster

Presentation AASLD 57th

Annual Meeting – Boston, MA Oct. 27-31, 2006

94. Rodrique JR, Balistreri W, Haber B, Jonas M, Mohan P, Molleston JP, Murrary KF,

Narkewicz MR, Rosenthal P, Smith LJ, Schwarz KB. Impact of Hepatitis C Virus (HCV)

Infection in Children: Quality of Life, Emotional, and Cognitive Outcomes. Abstract/Poster

presentation AASLD 57th

Annual Meeting – Boston, MA Oct. 27-31, 2006

95. Sokol RJ, Bezerra J, Haber B, Karpen S, Perlmutter D, Rosenthal P, Schwarz K, Shepherd R,

Shneider B, Whitington P, Brown M, Magee J, Robuck P, and Hoofnagle J for BARC. Biliary

Atresia Research Consortium (BARC): NIH funded network to advance knowledge and improve

care and outcomes in biliary atresia. Presented at Poster Session of NIH Workshop on Screening

and Outcomes in Biliary Atresia, Bethesda, MD., Sept. 11, 20006.

97. Narkewicz M, Olio DD, Karpen SJ, Krug S, Murray KF, Schwarz KB. et al. Pattern of

diagnostic evaluation for the causes of pediatric acute liver failure (PALF): Opportunities for

Quality Improvement. (AASLD Annual Meeting Boston, Mass Nov 2-6, 2007).

98. Shneider B, Shepherd R, Magee J, Bucuvalas JC, Haber B, Karpen SJ, Rosenthal P, Schwarz

KB, et al. Discriminating features of biliary atresia – A prospective multi-centered analysis.

(AASLD Annual Meeting Boston, Mass Nov 2-6, 2007).

99. Haber B, Balistreri WF, Bartob B, Gonzalez-Peralta RP, Goodman ZD, Jonas MM, Lobritto SJ,

Mohan P, Molleston JP, Murray KF, Narkewicz M, Robuck PR, Rosenthal P, Schwarz KB.

HCV autoimmunity in a U.S. multi-center cohort of treatment naϊve children. (AASLD Annual

Meeting Boston, Mass Nov 2-6, 2007).

100. Locke JE, Stewart ZA, Singer AL, Warren DS, Schwarz K, Maley WR, Montgomery RA,

Cameron AM. Hepatic artery thrombosis after pediatric liver transplantation: identification and

characterization of a novel risk factor. XXII International Congress of The Transplantation

Society, Sydney, Australia, mini-oral presentation

-46-

101. Locke JE, Stewart ZA, Singer AL, Warren DS, Schwarz K, Maley WR, Montgomery RA,

Cameron AM. Hepatic artery thrombosis after pediatric liver transplantation: identification of a

novel risk factor. 94th Annual Clinical Congress of the American College of Surgeons, San

Francisco, California, mini-oral/poster presentation.

102. Rosenthal P, Mohan P, Barton B, Robuck PR, Schwarz KB. Incidence of Neutropenia and

Impact on Sustained Virological Response (SVR) in Children and Adolescents with Chronic

Hepatitis C Treated with Peginterferon with or without Ribavirin: The PEDS-C Experience.

Hepatology 48(4)1623:1031A AASLD San Francisco, CA 2008

103. Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber B, Jonas MM, Mohan P,

Balistreri WF, Rosenthal P, Narkewicz MR, Smith LJ, Robuck PR, Barton B. Peg Interferon

with or without Ribavirin for Chronic Hepatitis C in Children and Adolescents: Final Results of

the PEDS-C Trial Hepatology 48(4):242;418A AASLD San Francisco, CA 2008.

104. Haber B, Fredericks EM, Magee J, Bezerra JA, Karpen SJ, Kerkar N, Rosenthal P, Schwarz KB,

Shepherd R, Shneider BL, Whitington PF, Robuck PR, Sokol RJ. Predictors of

neurodevelopmental outcome in non-transplanted children with biliary atresia at one year of age.

Hepatology 48(4) 1616:1028A AASLD San Francisco, CA 2008.

105. Schwarz KB, Shepherd RW, Magee J, Rosenthal P, Mack C, Raghumathan T, Bezerra JA,

Haber B, Karpen SJ, Shneider BL, Suchy FJ, Whitington PF, Robuck PR, Sokol RJ. Clinical

Demographic Features of Three Major Biliary Atresia Phenotypes in The BARC study.

Hepatology 48(4) 1615:1028A AASLD San Francisco, CA 2008.

106. Roy A, Colombani P, Lay H, Wilson L, Intihar P, Reeb B, Schwarz KB.

Two Decades of Experience with Pediatric Living Related and Deceased Donor Liver

Transplant. Hepatology 48(4):101;350A AASLD San Francisco, CA 2008.

107. Narkewicz M, Rosenthal P, Schwarz KB, Drack A, Margolis T, Repka M.

Opthalmologic Complications in Children with Chronic Hepatitis C Treated with Pegylated

Interferon: The PEDS-C Experience. NASPGHAN San Diego, CA 2008.

108. Clemente MG, Schwarz KB. Infection of human cholangiocytes and human hepatocytes with

SA11 rotavirus (The virus used for the murine biliary atresia model).

STC Conference on Cholangiocyte Biology 2008 Atlanta, GA.

109. Schwarz KB, Dell Olio D, Lobritto S, Lopez J, Rodriquez-Baez N, Yazigi N, et al.

An Analysis of Viral Testing in non-APAP Pediatric Acute Liver Failure (PALF)

Digestive Disease Week May 30- June 4, 2009 Chicago, Il.

110. Haber BA, Block JM, Jonas MM, Karpen SJ, London WT, McMahon B, Murray KF, Narkewicz

MR, Rosenthal P, and Schwarz KB. Management of Chronic Hepatitis B in Children in North

America: Report of a Workshop. Submitted to Pediatrics 2009.

111. Vasilescu A, Paranjape S, Karnsakul W, Schwarz KB. Design of a Pilot Study to Identify

-47-

Optimum Markers of Liver Fibrosis in Children with Cystic Fibrosis Liver Disease (CFLD)

CFLD clinical research workshop page 48.

112. Shneider BL, Abel R, Raghumathan T, Magee J, Bezerra JA,, Haber B,Karpen SJ,

Rosenthal P, Schwarz KB, Shepherd RW, Suchy FJ, Whitington PF, Robuck PR, and Sokol RJ:

A prospective multi-centered investigation of vitamin supplementation in infants with biliary

atresia: Interim analysis from the biliary atresia research consortium (BARC).

Publication Number: 698 AASLD Boston, MA 2009.

113. Sundaram SS, Fredericks EM, Kamath BM, Haber B, Raghumathan T, Magee JC,

Bezerra JA, Karpen SJ, Kerkar N, Rosenthal P, Schwarz KB, Shepherd RW, Shneider BL,

Whitington PF, Robuck PR, and Sokol RJ: A multicenter cross sectional assessment of quality of

life in biliary atresia patients aged 2-25 years. ID #699 AASLD Boston, MA 2009.

114. Molleston JP, Schwarz KB, Jonas M, Goodman Z, Rodrique J. Autoantibodies and

Autoimmune Disease during the PEDS-C trial. NASPGHAN Annual Meeting, November 12-

14, 2009, National Harbor, MD.

115. Haber BA, Narkewicz M, Schwarz KB. Recommendations for Screening, Monitoring and

Referral of Children with Chronic Hepatitis B in North America: Report of a Workshop

Pediatrics Editorial Office Nov 2009.

116 . Walsh MF, Wang T, Schwarz K, Crawford T, Hirano M, Wong L, Wang J, Cohn

RD. Compound Heterozygosity of the POLG1 Gene Presenting with Liver Failure

and Hypotonia. American Society of Human Genetics (ASHG) Meeting, Hawaii

October 23, 2009 (Accepted for Presentation).

117. Schwarz KB, Valsamakis A, Ballistreri WF, Gonzalez-Peralta RP, Haber B, Jonas MM, Mohan

P, Molleston JP, Murrary KF, Narkewicz M, Rosenthal P, Smith LJ, Rossi SJ, Robuck PR,

Barton B. Early changes in viral load predict sustained viral response (SVR) in the PEDS C

trial. Hepatology 50(4):240;419A AASLD Boston, MA 2009.

118. Jonas MM, Balistreri WF, Gonzalez-Peralta RP, Haber B, Mohan P, Molleston JP, Murray KF,

Narkewicz M, Rosental P, Schwarz KB, Smith LJ, Barton B. Changes in body mass index and

body composition in children treated with peginterferon for chronic hepatitis C in the PEDS-C

trial. Hepatology 50(4):708-636A AASLD Boston, MA 2009.

119. Rodrique JR, Balistreri JR, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz

M, Rosenthal P, Smith LJ, Schwarz KB, Robuck PR, Barton B, Gonzalez-Peralta RP.

Peginterferon alfa-2A with or without ribavirin results in minimal effect on quality of life,

emotional, and cognitive outcomes: results of the PEDS-C trial. Hepatology 50(4):238-418A

AASLD Boston, MA 2009.

120. Shneider BL, Abel RB, Raghumathan T, Magee JC, Bezerra JA, Haber B, Karpen SJ, Rosenthal

P, Schwarz KB, Shepherd RW, Suchy FJ, Whitington PF, Robuck PR, Sokil RJ. A prospective

multi-centered investigation of vitamin supplementation in infants with biliary atresia: interim

-48-

analysis from the biliary atresia research consortium (BARC). Hepatology 50(4):698-631A

AASLD Boston, MA 2009.

121. Sundaram SS, Fredericks EM, Kamath BM, Haber B, Raghumathan T, Magee JC, Bezzera JA,

Karpen SJ, Kerkar N, Rosenthal P, Schwarz KB, Shepherd RW, Shneider BL, Whitington PF,

Robuck PR, Sokol RJ. A multicenter cross sectional assessment of quality of life in biliary

atresia patients aged 2-25 years. Hepatology 50(4):699-632A AASLD Boston, MA 2009.

122. Sokol RJ, Magee JC, Hahn C, Robuck PR, Bezerra JA, Haber B, Karpen SJ, Molleston J, Murray

KF, Narkewicz M, Ng V, Padron-Turmelle Y, Romero R, Rosenthal P, Schwarz KB, Shneider

BL, Suchy F, Teckman J, Wang K, Whitington PF for the CHILDREN. The New Childhood

Liver Disease Research and Education Network (ChiLDREN): A Cooperative Endeavor between

NIDDK, Academic Centers and Patient Advocacy Groups. Presented NASPGHAN National

Harbor, MD Nov. 2009.

123. Clemente MG, Patton JP, Oh E, Anders R, Yolken RH, Schwarz KB. Rotavirus infection of

Human cholangiocytes results in release of IL-6 and IL-8 DDW, AASLD Pediatric Liver

Disease Session, New Orleans, La, May, 2010.

124. Clemente MG, Schwarz KB, Patton JP, Yolken RH, Parashar U, Parashar U, Whitington P,

Raghunathan T, Jiang B, FoyTich KR. Prevalence of acute asymptomatic group A rotavirus

infection in cholestatic infants enrolled in the Biliary Atresia Research Consortium (BARC) .

DDW, AASLD Plenary Session, New Orleans, La, May, 2010

125. Omenetti A, Bass L, Anders R, Clemente MG, Francis H, Guy CD, Shoi SS, Alpini G, Schwarz

K, Whitington P, Diehl AM. Hedgehog pathway drives the acquisition of mesenchymal markers

in ductular cells of patients with biliary atresia. Submitted AASLD 2010.

126. Shneider BO, Abel B, Haber B, Karpen SJ, Magee JC, Romero R, Schwarz KB, Bass L, Kerkar

N, Miethke A, Rosenthal P, Turmelle Y, Kokol RJ. Cross-sectional Multi-center Analysis of

Portal Hypertension in 163 Children with Biliary Atresia. Submitted to AASLD 2010.

127. Clemente MG, Schwarz KB. Rotavirus (RV) infection of Human Cholangiocytes results in

Release of IL-6 and IL-8. NASPGHAN 2010.

128. Clemente MG, Schwarz KB, Patton JP, Yolken RH, Parashar U, Parashar U, Whitington P,

Raghunathan T, Jiang B, FoyTich KR. Prevalence of acute asymptomatic group A rotavirus

infection in cholestatic infants enrolled in the Biliary Atresia Research Consortium (BARC) .

NASPGHAN 2010.

129. Lucas JE, Patel K, Thompson JW, Dubios L, Thompson A, Tillmann H, Clark PJ, McCarthy JJ,

Moseley MA, Schwarz KB, McHutchison JG. Validation of a label-free proteomics predictor of

response to therapy in pediatric CHC patients. Submitted AASLD 2010.

130. Shneider BL, Magee JC, Karpen SJ, Rand E, Markewicz M, Schwarz KB, Whitington PF, et al.

Prospective Multicenter Analysis of Post-operative Total Bilirubin as a Biomarker for Short-term

-49-

Outcome after Hepatoportoenterostomy for Biliary Atresia. AASLD 2011.

131. Ng VL, Haber B, Magee JC, Bezerra JA, Whitington PF, Schwarz K, et al. Health Status of 192

Children with Biliary Atresia Surviving >5 years After Kasai Portoenterostomy with Their

Native Liver: How are They Doing? AASLD 2011.

132. Shneider B, Robuck P, Rosenthal P, Schwarz KB, Karpen SJ, Narkewicz M, Magee J.

"Prospective Multicenter Analysis of Post-operative Total Bilirubin as a Biomarker for Short-

term Outcome After Hepatoportoenterostomy for Biliary Atresia" oral presentation at the 62nd

Annual Meeting of AASLD in San Francisco, California, November 4 - November 8, 2011.

HEPATOLOGY 2011:54;(4)114A.

133. Karnsakul W, Schwarz KB. Financial and Clinical Analysis of Living related Liver

Transplantation in Children: A Single Center Experience. (1136294) AASLD

HEPATOLOGY 2011:54 (4);170A.

134. Ng VL, Haber B, Magee J, Karpen S, Miethke A, Schwarz K, et al. Report from ChiLDREN:

Medical Status of 192 Children with Biliary Atresia Surviving >5 years After Kasai

Portoenterostomy With Their Native Liver. AASLD HEPATOLOGY 2011:43(4);175a.

135. Hourigan SK, Anders RA, Mitchell SE, Schwarz KB, Lau H, Karnsakul W. Protein-losing

enteropathy in an infant with hepatic venous outflow obstruction after liver transplantation.

Presented at NASPGHAN Orlando, Fl 2011.

136. Schwarz KB, Ling S, Rosenthal P, Murray K, Rodriguez-Baez N, Teckman J, Schwarzenberg S,

Li R and Belle SH for the Hepatitis B Research Network (HBRN) Phenotypes of North

American children with hepatitis B virus (HBV) infection. AASLD Annual Meeting, Boston,

Mass.

137. Koeck ES, Iordanskaia T, Devadason C, Rossi C, Anders R, Schwarz K, Nadler EP. .

Integrin Beta-8, but not Beta-5 or -6, Protein Expression is Increased in Livers of Children with

Biliary Atresia. NASPGHAN Orlando, Fl 2012.

138. Schwarz KB. Cost-effective analysis of screening for biliary atresia with the stool color card

(ID# 1734263). Presented at AASLD 2013.

139. Schwarz KB. Seroprevalance of Anti-IgG and Anti-IgM Antibodies to Hepatitis E Virus in Solid

Organ Transplant Recipients at a North American Transplant Center (ID # 1736615. Presented

at AASLD Annual Meeting 2013.

140. Schwarz KB. Determinants of cost in biliary atresia (ID# 1734453) presented at AASLD Annual

Meeting 2013.

141. Bezerra JA, Spino C, MaGee JC, Shneider BL, Rosenthal P, Wang KS, Erlichman J, Haber B,

Hertel PM, Karpen SJ, Kerkar N, Loomes KM, Molleston JP, Murray KF, Romero R, Schwarz,

KB, et al. High-dose corticosteroid therapy following portoenterostomy in infants with biliary

-50-

atresia does not improve outcome: The multi-center, randomized, double-blind, placebo-

controlled START Trial (ID# 1737851). To be Presented AASLD Annual Meeting 2013.

142. Sue P, Pisanic N, Forman H, Heaney C, Schwarz K, Nelson K, Karnsakul W. Variability of

Hepatitis E serologic assays in a pediatric liver transplant recipient: Challenges in the diagnosis

of Hepatitis E infection among at risk individuals. To be presented to NASPGHAN 2013.

143. Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Schwarz KB. A randomized trial of

corticosteroids in infants with biliary atresis: The multi-center START trial. AASLD 2013,

Washington, DC.

144. Jonas M, Schwarz K, Sokal E, Reynolds L, Thiry A, Kelly D. A comparative study of the

antiviral efficacy and safety of entecavir versus placebo in HBeAg-positive pediatric subjects

with chronic hepatitis B. Poster of distinction APASL 2014 (March 12-15, Brisbane Australia.

145. Schwarz, KB. AASLD Washington, DC 2013.

146. Mogul D, Teckman J, Cloonan YK, Schwarz K, MacGregor JM. Drug resistance, basal core

promoter and pre-core stop mutations in a large cohort of North American children with

Hepatitis B: Results for the Pediatric Cohort Study of the NIDDK-Sponsored Hepatitis B

Research Network (HBRN) (1895577), Digestive Disease Week at McCormick Place

Convention Center in Chicago, IL, May 3 - May 6, 2014.

147. Schwarz K. Moleston JP, Jonas MM, Wen J, Murray K, Rosenthal P, Gonzalez-Peralta RP,

Lobritto SJ, Mogul D, Hooper G, Warne C, Thompson B. Long-term Durability of Sustained

Viral Response (SVR) in Children Treated for Chronic Hepatitis C (PEDS C Trial) (1903048)

lecture presentation during Digestive Disease Week, at McCormick Place Convention Center in

Chicago, IL, May 3- May 6, 2014.

148. Sue PK, Pisanic N, Nelson K, Schwarz KB, Heaney C, Montgomery R, Jackson A, Ticehurst J,

Forman M, Valsamakis A, Karnsakul W. Hepatitis E Virus Infection among Solid Organ

Transplant Recipients at a North American Transplant Center. Infectious Disease Society of

America 2014.

149. Ng VL, Haber BH, Magee JC, Miethke A, Murray KF, Michail S, Karpen SJ, Kerkar N,

Molleston JP, Romero R, Rosenthal P, Schwarz KB, Shneider BL, Turmelle YP, Alonso EM,

Sherker AH, and Sokol RJ, on behalf of the Childhood Liver Disease Research and Education

Network (CHiLDREN. Medical Status of 219 Children with Biliary Atresia Surviving Long-

Term with Their Native Livers: Results from a North American Multicenter Consortium.

The Journal of Pediatrics . 2014

150. Kelly D, Jonas M, Schwarz KB, Orasenau D, Reynolds L, Sokal E, Thiry A. Bargaje R, Gupta

K. “A comparative study of the antiviral efficacy and safety of entecavir versus placebo in

HBeAg-positive pediatric subjects with chronic hepatitis B”. Poster presented at APASL 2014.

-51-

151. Sue PK, Pisanic N, Nelson K, Schwarz K, Heaney C, Montgomery R, Jackson A, Ticehurst J,

Forman M, Valsamakis, A, Sanyal A, Karnsakul W. Characteristics of Post Transplantantion

Hepatitis E Virus Infection Amng Solid Organ Transplant Recipients at a North American

Transplant Center. To be presented at AASLD Boston, MA 2014.

152. Hsinghua Sylvia Lin, Sarah Jane Schwarzenberg, Yona Keich Cloonan , Simon C. Ling, Karen

F. Murray, Norberto Rodriguez-Baez, Philip Rosenthal, Jeffrey Teckman, Kathleen B. Schwarz.

Health-Related Quality of Life in Youth with Chronic Hepatitis B in the United States and

Canada: Pediatric Cohort of Hepatitis B Research Network . Dean’s Day Poster Competition,

University of Pittsburgh Graduate School of Public Health. 2015